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ABSTRACT 
Annually, over 5.7 million Americans are diagnosed with two IVD-associated 
pathologies: IVD herniation (IVDH- a mechanical disruption of the concentric fibrous 
layers of the annulus fibrosus (AF))) and degeneration (IVDD- a multifactorial process 
which initiates within the inner gelatinous core (NP), and results in a biochemical 
degradation of NP tissue), with over 2.7 million requiring surgical inteventions.1,2 
Although both underlying pathologies are different, quite often they both lead to a decrease 
in IVD height, impaired mechanical function, and increased pain and disability. These pain 
symptoms affect approximately 80% of the adult population during their lifetime with 
estimated expenditures exceeding $85.9 billion.3,4 
Current surgical procedures for IVDH and IVDD are palliative and suffer from 
drawbacks. While they are performed to address patient symptoms, they fail to address the 
underlying pathology of a defect remaining within the subsequent layers of the AF. An 
effective AF closure/repair device in conjunction with a less aggressive discectomy for 
IVDH and/or NP arthroplasty for IVDD, may result in improved patient outcomes, 
decreased pain, and provide fewer revision surgeries via lower re-herniation and expulsion 
rates.5,6 Therefore, an intact AF must be re-established to prevent implant expulsion or re-
herniation, thus addressing the two major spinal pathologies directly associated with an 
IVD.  
Currently within the medical device market, no tissue engineering biomaterials are 
available for AF closure/repair. Current market AF closure devices (Intrinsic Barricaid®, 
Anulex X-Close® Tissue Repair System, and Anulex Inclose® Surgical Mesh System) are 
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synthetic materials focused solely on preserving and reinforcing the native tissue and lack 
efficient strategies for implantation, fixation, and regeneration. Therefore, there has been 
an increase in tissue engineering and regenerative therapeutic approaches aiming for 
structural and biological AF repair investigated over the last decade using in vivo and in 
vitro experimentation. It is proposed that the optimum AF tissue engineering scaffold 
should reproduce the architecture, and the mechanical properties of the native human AF 
tissue.7 Recent articles illustrate several novel suture, seal, and barrier techniques currently 
under development, resulting in an increasing attention at scientific workshops and 
conferences.8–15  
To develop a tissue engineering biomaterial that is suitable for AF closure it must 
meet the following criteria: (1) mimic the structural angle-ply architecture of the native 
AF, (2) withstand static and dynamic mechanical properties mimicking the native 
functional characteristics, and (3) express cytocompatibility while promoting tissue 
regeneration. Current biomaterials growing attention in the tissue engineering academic 
field, electrospinning, polymers, glue, silk scaffolds, and honeycomb-scaffolds, require 
complex manufacturing procedures and typically work to address two of the three criteria 
(mimicking the biological and structural characteristics).5 Although the mechanical 
advantage of closing annular defects to retain NP material seems intuitive, only recently 
have AF closure devices begun to examined in human cadaveric or animal tissues for their 
ability to withstand in situ IDP or flexibility testing.16 Therefore, the use of decellularized 
tissue from a xenogeneic source is ideal due to its advantage of maintaining native 
extracellular matrix (ECM) while also removing all potential harmful xenogeneic factors.  
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We propose to address all three criteria with the development of a biomimetic 
angle-ply annulus fibrosus patch comprised of decellularized porcine pericardium. Porcine 
pericardium was chosen due to its native type I collagen content, mechanical strength, and 
cytocompatibility. The objectives of this research were to investigate the development of a 
biomimetic patch, consisting of decellularized porcine pericardium, to biologically 
augment AF repair by (1) characterizing the micro-architecture of the multi-laminate angle-
ply AF patch, (2) evaluating the mechanical properties through static and dynamic tensile 
loading and impact resistance of IDP, and (3) evaluating the cytocompatibility of the patch 
using a healthy alternative cell source for AF tissue regeneration.  
v 
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CHAPTER I 
LITERATURE REVIEW 
BACKGROUND 
Low back pain (LBP) affects approximately 80% of the adult population during 
their lifetime with estimated expenditures exceeding $85.9 billion.3,4 Patients suffering 
from LBP often experience a diminished quality of life. Within the United States of 
America, LBP is the most common cause of activity limitation in people under the age of 
45, the 2nd most frequent reason for doctor visits, the 5th leading cause of hospital 
admission, the 3rd most common surgical procedure, and the most common cause of job-
related disability leading to days missed on the job.2,17–19 Although LBP is multifactorial; 
LBP can originate from intervertebral disc (IVD) pathologies. Annually, over 5.7 million 
Americans are diagnosed with two IVD-associated pathologies: IVD herniation (IVDH- a 
mechanical disruption of the concentric fibrous layers of the annulus fibrosus (AF))) and 
degeneration (IVDD- a multifactorial process which initiates within the inner gelatinous 
core (NP), and results in a biochemical degradation of NP tissue), with over 2.7 million 
requiring surgical intervention.1,2 Although both underlying pathologies are different, quite 
often they both lead to a decrease in IVD height, impaired mechanical function, and 
increased pain and disability. 
INTERVERTEBRAL DISC ANATOMY, PHYSIOLOGY, AND PATHOLOGY 
An IVD links adjacent vertebral bodies together to provide mobility and stability 
to the spine. The IVD’s function is to support compressive loads arising from body weight 
and muscle forces while allowing for motion. There are 23 IVD’s in the human spine: 6 
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cervical, 12 thoracic, 5 lumbar. The IVD is divided into three distinct regions as seen in 
Figure 1: nucleus pulposus (NP), annulus fibrosus (AF), and hyaline cartilaginous 
endplates.20  
Figure 1: Intervertebral Disc Overview21 
During early development, IVD’s have some vascular supply to the cartilage 
endplates and AF, but these supplies quickly deteriorate leaving nearly no direct blood 
supply in healthy adults.22 Thus, making these the largest, avascular structures in the human 
body. IVD’s are composed of three major constituents: water, fibrillar collagens, and 
aggrecan (cartilage-specific proteoglycan). The proportion and organization of these 
components vary considerably with position across the IVD, for example, the NP has a 
higher concentration of aggrecan and water, but a lower collagen content than other regions 
of the IVD.23 Collagen proportions change based on location in the IVD, with the NP 
containing only type II collagen while both types I and type II are found in the AF.24   
The NP is the central proteoglycan and collagen Type II rich core distributes 
intradiscal pressure arising from applied compressive loads. The NP is comprised of a large 
aggregating proteoglycans, which contains a protein core. Up to 100 highly sulphated 
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glycosaminoglycan (GAG) chains, principally chondroitin and keratin sulphate, are 
covalently attached to a core protein.25 The chains are long, linear carbohydrate polymers 
that have a net negative charge under physiological conditions. This negative charge 
attracts positively charged sodium ions which in return lures water molecules via osmosis. 
Research studies have proven a negative correlation between age and degeneration to the 
amount of water and GAGs present within the NP.26 As GAGs begin to diminish overtime, 
it is replaced with fibrocartilage. The presence of fibrocartilage found in IVDs as GAGs 
diminish is a protective adaptation to physiological conditions.  
The AF consists of circumferential exterior collagen sheets and is an essential 
constituent of the intervertebral joint. The AF is comprised of approximately 15-25 
collagen sheets (lamellae), per IVD, which encompasses the NP.27 These lamellae are 
comprised of type I collagen fibers that are aligned in alternating patterns of ± 30 degrees 
to the horizontal axis of the spine.28 The AF can is divided into three layers: peripheral, 
intermediate, and inner regions. The annulus fibers are found to be thicker and more 
numerous anteriorly than posteriorly while the posterior fibers express a more parallel 
alignment.29 The bundles of fibrous cartilage (multi-layers) runs obliquely from one 
vertebral body to the next to anchor the IVD to the cartilaginous endplates.  
The hyaline cartilaginous endplates allow for nutrient supply to the IVD. Since 
IVD’s are avascular structures, they are dependent on the endplates for nutrient diffusion. 
By the age of eight, the cartilaginous endplates lose their blood supply, leaving holes from 
blood vessels that allow for the diffusion of metabolites.29 These holes which are essential 
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for the supply of nutrients also cause structural deficiencies (weakness) to the endplate 
structure.  
CLINICAL SIGNIFICANCE OF INTERVERTEBRAL DISC DISEASES 
In a clinical setting, two relevant pathologies directly affect the IVD: IVD 
herniation (IVDH) and IVD degeneration (IVDD). An IVDH is referred to as a “herniated 
disc”, “bulging disc”, or “slipped disc”. IVDH as a consequence of traumatic (quick jolting 
motion), typically results in painful circumstances for the patient via nerve root 
impingement. As an IVDH begins to form, the AF begins to degrade and rupture progress 
radially through its layers. This results in a loss of IVD height, a decrease in IDP, and in 
many cases contributes significantly to LBP. This defect provides a pathway for the NP to 
bulge or migrate beyond the confines of the AF layers that can apply pressure to a nearby 
nerve within the spinal canal, “pinched nerve.” The applied pressure leads to irritation of 
the nerve which depending on the level of intensity may lead to a radicular pair. Radicular 
pain is a pain that radiates to the extremities of the body, i.e. arm and legs, which travels 
directly along the course of a spinal nerve root. A “pinched nerve” may lead to symptoms 
of dull/sharp pain in the lower back, muscle spasms/cramping, sciatica, leg weakness, 
and/or loss of leg function. Although it is important to express, not all patients who develop 
an IVD herniation experience symptoms of pain.  
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Figure 2: Stages of Disc Herniation (IVDH)30 
There are four stages of IVD herniation as seen in Figure 2: Stage 1) Annular tear: 
IVD is intact, but a small tear in the outer layer (without herniation), Stage 2) Prolapse: the 
form of position of the IVD changes with some slight impingement into the spinal canal 
(i.e. bulge or protrusion), Stage 3) Extrusion: the gelatinous core of the NP breaks through 
the collagen sheets of the AF but remains within the IVD, Stage 4) 
Sequestration/Sequestered Disc: the NP breaks through the AF and lies outside the IVD in 
the spinal canal.31 The most frequently affected IVDs via IVDH are IVDs with the most 
substantial range of motion and/or axial loading forces: L3-4, L4-5, L5-S1.  
IVDD is a prevalent musculoskeletal disease seen through the aging population. 
IVDD occurs via a multifactorial process that results in biochemical degradation of NP 
tissue, a decrease in IVD height, a decrease in IDP, and loss of mechanical function. IVDD 
is linked to multiple factors in the initiation and progression of the disease: aging, poor 
nutrient supply, loading conditions, and hereditary factors.32–38 Consistent IDP changes of 
the NP result in assuage of the posterior AF. This is identified as part of the aging process 
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after 45 years of age, thus resulting in total annular lamellae disorganization by the age of 
80.39,40 A research study showed through magnetic resonance imaging (MRI) 20% of 
patients tested over 45 years of age have an IVD bulge or IVDD, and nearly 60% of patients 
over 65 years of age had IVDD.41  
IVDD is a loss of both hydraulic and viscoelastic properties of the IVD through 1) 
a decrease in the water content and, therefore, a reduction of the preloading effect of the 
NP, 2) a decrease in the elastic collagen tissue in the annulus with replacement of large 
fibrous inelastic bands, and 3) cartilage degeneration in the endplates.29 IVDD is 
characterized by changes identified in the cellular microenvironment, loss of proteoglycan, 
loss of IVD height, tears of AF tissue, spinal stenosis, herniated discs, neoinnervation, 
hypermobility, and inflammation.42–45 
Degeneration is diagnosed on a grading scale of 0-4 of the IVD (Figure 3)and can 
be referred to the degeneration of the facet joint: Grade 0) no changes in the physiological 
IVD, Grade 1) joint space narrowing, Grade 2) narrowing in addition to sclerosis or 
hypertrophy, Grade 3) severe osteoarthritis in addition to beginning narrowing, sclerosis, 
and osteophytes, and Grade 4) advanced osteoarthritis in conjunction with hypertrophy, 
narrowing, sclerosis, and osteophytes.46  
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Figure 3: Stages of Disc Degeneration (IVDD)47 
The level of degeneration has a correlating effect on the amount of IDP observed 
by the IVD. The mean IDP showed a statistically significant difference between each grade 
of degeneration, with IDP reduced with increasing levels of degeneration.48  The IDP in 
the L4-L5 IVD measured in a patient with a grade 0 degeneration presented a mean of 
0.091 [MPa] while a patient with a grade 4 degeneration displayed a mean IDP of 0.010 
[MPa].48  
CURRENT TREATMENTS OF INTERVERTEBRAL DISC DISEASES 
Treatment plans for LBP are dependent on the patient’s history and the 
type/severity of pain. Until recently, clinicians believed pain due to herniation would 
resolve on its own without surgical intervention (i.e. spontaneous resorption of the 
herniation). However, despite a temporary reduction in pain, a recent study showed that 
when herniation’s are not treated, a resurgence of the pain does in fact occur. The study 
investigated the course of LBP in a general population of 2000 people aged 30-50 years 
over a five year period. The study found that for more than 33% of people who experienced 
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LBP, the pain lasted for >30 days, and out of these 33% of patients, only 9% were pain-
free five years later.49  
 The treatment method utilized by a physician is often dependent on the type of 
injury of the patient, with IVDD and IVDH requiring different treatment approaches. 
IVDH treatments typically begin with bed rest, NSAIDs, and pain-medications. Sometimes 
physical therapy (PT) may also be prescribed to improve the patients’ symptoms. However, 
if symptoms persist, epidural injections of corticosteroids to reduce the nerve irritation and 
facilitate healing may be assessed. If a patient is not responding to 6-12 weeks of 
conservative conventional treatments, surgical intervention is often considered. For 
patients suffering from LBP, a microdiscectomy, and/or laminectomy may be performed. 
Within the United States, (U.S.) lumbar discectomy is the most frequently completed 
procedure to repair an IVDH, with over 300,000 operations performed annually.,50 with an 
associated direct cost of approximately $3,445 per case.51    
 The surgical approach to a discectomy procedure, “minimal or aggressive,” is based 
on the surgeons’ personal preference. Both techniques have favorable and unfavorable 
results, pros and cons. The objective of the surgical procedure, to be considered a complete 
success, provides the maintenance of the patients’ IVD height, and experiences low 
reoccurrences of IVDH. By maintaining the patient’s IVD height, this provides better 
patient outcomes. A “minimal” discectomy maintains the IVD height, but is at an increased 
risk of reherniation. While an “aggressive” discectomy reduces the reoccurrence of 
herniation’s, it is linked with IVD height collapse.52–54 In both surgical approaches, there 
is the partial removal of the protruding herniated NP tissue and decompression of the neural 
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elements. During the procedure, a laminotomy/laminectomy, a small piece of the vertebrae 
removed, may need to be performed to provide access to the herniated fragments. This 
laminotomy permits a more advantageous visualization for the surgeon of the herniated 
fragments of the IVD. Consequently, by removing the herniated IVD fragments via 
discectomy, an open pathway (defect) remains through the layers AF, which provides a 
path of least resistance for recurrent herniation’s to occur. Regardless of surgical approach, 
an average IVD height loss of 25% has been reported after a discectomy, which is 
associated with increased back pain and disability.50 Various studies have shown that 
reoperation rates range from 9-25% at 4 and 10 years post-operatively,55–59 which results 
in direct costs ranging from $2.5k for conservative management to 35k for surgical re-
intervention, respectively per case.60,61 It is imperative to express, current discectomy 
procedures are not directed to treat the damaged IVD, but rather to alleviate patients’ 
symptoms that may result in further aggravation of existing damage.10,62,63 Since 
discectomies are still the most performed spinal surgical procedure worldwide and mainly 
affects the employed population, the resulting socio-economic consequences are 
significant.64 
 Alternatively, IVDD is often managed with over-the-counter pain medications (i.e. 
NSAIDS), and applying ice/heat to the affected area. More aggressive treatments include 
physical therapy (PT), chiropractic manipulation, electrical stimulation, massage, and last 
surgery. With surgical interventions, surgical treatments of IVDD are focused towards 
treating symptoms experienced by the patient rather than restoring native structure and 
function.  
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Currently, two IVDD surgical procedures are performed: spinal fusion and total 
disc replacement (TDR).  Both procedures have an objective to preserve the IVD height as 
seen in Figure 4. The traditional procedure, often considered as the “gold standard” 
surgical treatment, for an IVDD, is the generation of a bony fusion between two vertebral 
bodies to reduce spinal instability and minimize pain.65 Shortcomings of a fusion procedure 
include adjacent segment degeneration and other complications; thus, it is typically 
employed as a last resort option. Spinal fusions are approached from either the posterior or 
anterior position. While historically the posterior approach has been used, the anterior 
approach allows the surgeon to leave an IVD space that more likely will result in the patient 
having greater pain relief.66 The cost of spinal fusion typically ranges between $80k to 
$150k per case; a significantly greater cost as compared to a discectomy procedure. 
 
Figure 4: IVDD End-Stage Devices Used for Surgical Repair.67 Left) Lumbar Fusion 
Device. Right) Lumbar Artificial Disc Replacement 
The more contemporary surgical procedure, TDR, consists of the removal of the 
damaged IVD, but maintenance of motion is achieved by the use of a prosthetic implant. 
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However, during a TDR only one of the three joints of the vertebra is replaced, thus limiting 
the range of motion.68 Long-term clinical data is still needed to validate the efficacy of 
TDR.69 Due to adjacent segment disorders seen with spinal fusions and lifetime of TDR 
devices revision surgery is an important factor that must be addressed with these clinical 
procedures. Clinical outcomes have shown that patients undergoing revision fusion surgery 
exhibited significantly higher rates of unfavorable discharge, prolonged length of stay at 
the hospital, high-end hospital charges, neurologic complications, pulmonary embolism, 
wound infections, wound complications, and gastrointestinal and respiratory 
complications.70 
REPAIR OF THE IVD 
 With the short-term lifespan of mechanically assisted devices and limitations of 
patient’s mobility, repair and/or regeneration of the IVD is needed to restore it to its healthy 
native state. A functional AF must be capable of withstanding the mechanical static and 
dynamic tensile, burst, and impact loading saw in a healthy IVD. To accomplish this 
ideology, it is advantageous and obligatory to have an intact AF to allow for native 
physiological and functional capabilities.  
Current surgical procedures for IVDH and IVDD are palliative and suffer from 
drawbacks. Depending on the amount of herniated material removed, patients undergoing 
discectomy can be at an increased risk for re-herniation.55,59 Treatments for IVDD, as stated 
above, are end-stage surgical interventions that could benefit from an early stage solution, 
such as nucleus arthroplasty. Current research is being conducted on developing an 
artificial NP, which would be used for replacing the degenerated native material; however, 
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the defect in the AF would remain after implantation and migration, respectively. 
Therefore, in both clinical scenarios it would be advantageous and obligatory to have an 
intact AF to prevent re-herniation. Accompanying techniques that treat the damaged AF 
are now increasingly recognized as mandatory to prevent re-herniation, to increase the 
potential of NP repair, and to confine NP replacement therapies that target early-stage 
IVDD and IVDH.71  
These shortcomings and drawbacks of current surgical procedures constitutes a 
need in which the tissue engineering discipline may be applied to repair the native IVD.  
ANNULUS FIBROSUS STRUCTURE 
The AF is comprised of circumferential exterior sheets (lamellae) comprised of 
collagen type I and is an essential constituent of the intervertebral joint. The AF is divided 
into three layers: peripheral, intermediate, and inner segments. The annulus fibers are found 
to be thicker and more numerous anteriorly than posteriorly while the posterior fibers 
express a more parallel alignment.29 The bundles of fibrous cartilage (multi-layers) runs 
obliquely from one vertebral body to the next to anchor the IVD to the cartilaginous 
endplates. The formation of the AF begins at the mesoderm germ layer, one of the three 
primary germ layers in the early stages of embryonic development. The middle 
embryological germ layer, mesoderm, forms the mesenchyme that during embryogenesis 
develops the AF.72 The composition of the AF is comprised of four main elements: water, 
collagen, proteoglycans, and non-collagenous proteins. The physiological classification by 
percentage of these elements is as follows: water (65-90%), collagen (50-70% dry weight), 
proteoglycans (10-20% dry weight), and non-collagenous proteins (i.e. elastin) (5-25%).73–
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75 Within the internal portions of the AF, the layers are less hydrated than the NP  and more 
widely dispersed in comparison to the exterior region of the AF.76 The interior AF also 
consists of a more substantial amount of GAGs in comparison to the exterior region of the 
AF: aggrecan and versican.77–81 Small proteoglycans are found in greater amounts in the 
internal region: biglycan, decorin, fibromodulin, and lumican.82–84 The distribution of type 
I and II collagen also fluctuate based on location within the AF. The exterior lamellae 
consist purely of type I collagen, but as you move interiorly toward to the NP, overall type 
II collagen percentage increases as type I collagen percentage decreases. The internal AF 
is mainly composed of type II collagen, although other collagen types such as III, V, VI, 
IX, and XI were detected within the inner AF.85 
The highly organized structure of the AF results in a complex anisotropic behavior, 
with tensile, compressive, and shear properties differing in the axial, circumferential, and 
radial directions.74,86,87 The AF is comprised of collagen sheets (lamellae) with 
approximately 15-25 lamellae, per IVD,27 which the fibers are aligned in alternating 
patterns of ± 30° to the horizontal axis of the spine, as seen in Figure 5.28  
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Figure 5: Annulus Fibrosus Lamellae. Arranged in alternating patterns 
between subsequent layers.88  
The composition of the lamellae is filled with proteoglycans and interspersed with 
elastin fibers.89 In the exterior AF, long elastic fibers are present within the lamellae, 
running parallel to each other in the same direction as the collagen sheets. However, within 
the internal AF, the elastic fibers are present between adjacent lamellae as well as increased 
regular organization within the lamellae.90 The spaces located between the separate layers 
of the AF are called interlamellar septae, and they contain proteoglycan aggregates, and a 
complex structure of linking elements creating interlamellar cohesion.73,91,92 The ends of 
the collagen sheets run obliquely from one intervertebral body to the next to attach/secure 
the IVD to the endplates.  
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MECHANICAL PROPERTIES OF NATIVE ANNULUS FIBROSUS 
Mechanically, the interior AF region is subjected to higher IDP generated from the 
NP as opposed to higher tensile forces exerted on the exterior region.93,94 Together these 
fiber networks couple adjacent lamellae together allowing them to work co-operatively 
during dynamic loading and prevent separation of lamellae during torsional compressive 
loading.95  
The posterolateral location of the AF experiences the highest frequency of layer 
interruption from various mechanical forces.96,97 This region is also where the highest 
stresses are observed during loading,98 and where annular tears, fissures, protrusions, 
extrusion, and/or sequestrations are known to develop.99 Table 1 illustrates the mechanical 
characteristics of the native AF.  
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Table 1: Mechanical Characteristics of the Native AF Tissue 
 
 
HEALING POTENTIAL OF THE ANNULUS FIBROSUS 
To unlock the potential for AF regeneration, the native healing potential needs to 
be addressed. The intrinsic capacity of the AF to cope with damage or degenerative 
pathological changes have been studied in several animal trials.103–112 Key and Ford studied 
the healing capacity of three different types of posterior annulus lesions in a canine model: 
square annular window, transverse incision, and puncture with 20 gauge needle (0.91 
mm).107 During post-operative procedures, the lesions were initially filled with 
extravasated blood, fibrin, bone, and cartilage debris. These were gradually replaced by a 
Property Value 
Dimensions L4/L5 IVD  IVD Width: 30.4 ± 4.5 mm100 
NP Width: 19.3 ± 2.9 mm100 
Anterior AF: 20.5% (total IVD)100 
Posterior AF: 15.6% (total IVD)100 
Burst Strength Slit (6 mm vertical): 0.93 [MPa]16 
Circular Opening (3 mm): 0.64 [MPa]16 
Ultimate Tensile Strength Anterior: 1.7 ± 0.8 [MPa]101 
Posterior: 3.8 ± 1.9 [MPa]101 
Elastic Modulus Anterior: 7.2 ± 3.1 [MPa]101 
Posterior: 27.2 ± 10.2 [MPa]101 
Overall 12-24 [MPa]102 
Tensile Fatigue 1043 cycles at 2.3[MPa]101 
10,000 cycles at 1.7 [MPa]101 
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thin layer of fibrous tissue at later time points (up to 22 weeks). While the larger damaging 
lesions (window and incision lesion groups) developed slowly towards IVD protrusion, the 
lesions that were generated by needle puncture revealed nothing irregular and the site of 
puncture was unidentifiable after 22 weeks. This study was contradicted however using 
rabbit IVDs as an organ culture model. The needle puncture showed immediate and 
progressive mechanical and biological consequences that could lead to degenerative 
modeling if longer time points were observed.113 
Smith identified the healing process of the AF occurs in three different phases. In 
the 1st phase, the outer AF begins to heal. This is caused by a proliferative reaction in the 
fibrous tissue spreading from the lateral parts of the wound to the medial parts. During the 
2nd phase changes occur in the inner annular fibers. The lateral parts of the interior AF 
layers gradually heal by a slow appositional spread in the medial direction.  The process 
normal begins after a few weeks, but can last up to one-year post-operatively. During the 
3rd phase, an increase in the number of collagenous fibers found within the NP tissue, which 
has remained in the AF wound tract, become increasingly dense.112  
Although many hypotheses has been formed on what leads to the limited intrinsic 
healing capability of the AF, many contributing factors remain unknown. One of those 
reasons may be the fact that exterior repairs are not matched, or insulated to the demands 
of progressive recruitment of fibers to a tensile force.114,115 Nevertheless, no matter the 
underlying reason of why, the limited intrinsic healing capability of the native AF 
negatively correlates with the success rates of discectomies and NP replacement 
therapies.71 
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ANNULUS FIBROSUS CLOSURE TECHNIQUES 
 
COMMERCIALLY AVAILABLE PRODUCTS 
With tissue engineering, medical devices still in the primitive stage, mechanical 
closure of the AF is the most effective closure technique currently available on the market. 
It has been proposed that improved annular closure procedures may reduce IVD re-
herniation, and reduce the need for spinal fusion. The most straight-forward solution is per 
operative suturing of the AF defect. However, suturing does not account for missing AF 
tissue and may not be strong enough to resist changes of the IDP generated by the NP tissue 
under different loading regimes. Efficacy and efficiency of suturing the AF have been 
studied by Ahlgren et al. in an animal study of an ovine model. It was reported that sutured 
IVDs showed a tendency towards stronger healing, but the results were not statistically 
significant.103 As the investigation of an AF closure device continues, Johannes Bron states, 
the clinical durability the eventual arbiter of technological value.71  
A diversity of medical devices have been designed or are currently being studied to 
preserve, repair, and reinforce the AF. The following devices are currently marketed for 
the proposed use in AF closure after a discectomy to reduce the risk of re-herniation. 
Anulex Technologies, Inc. has developed two devices: Xclose Tissue Repair System and 
Inclose Surgical Mesh System. Intrinsic Therapeutics developed the Barricaid Annular 
Reconstruction Device. Lastly, Magellan Spine Technologies, Inc. has developed the Disc 
Annular Repair Technology (DART) System. Table 2 illustrates a comparison of AF repair 
devices currently available on the market.  
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Table 2: Comparison of AF Repair Devices Currently Available on the 
Market 
 
 The Xclose Tissue Repair System received a 510(k) clearance on August 7th, 2006. 
The Xclose system consists of non-absorbable, synthetic, poly(ethylene terephthalate) 
surgical sutures modified with toggle anchors. The FDA labeled indications state the 
system is used for soft tissue approximation in general and orthopedic surgery procedures. 
The use of an AF repair was later deemed as outside the scope of the 510(k) clearance. The 
FDA required the manufacturer to submit a premarket approval application (PMA), in 
conjunction with clinical data from an investigational device exemption (IDE) study. 
Xclose and Inclose implants are now commercially available for annuloplasty and can be 
seen as modified sutures with anchors.9,11 
 The Inclose Surgical Mesh System received FDA 510(k) clearance on August 18, 
2005. The surgical mesh is comprised of polyethylene terephthalate (PET) monofilament 
Product Company Description Limitations
Barricaid Annulus 
Closure Device 
Intrinsic Therapeutics 
Polyethylene Terephthalate 
and Titanium Bone Anchor
Long-term  (>2 years) results showed no significant 
reduction in reherniation rates. Potential issues with 
migration of device. Device lacks ability to regenerate 
and remodel with host tissue 
Xclose Suturing System Anulex Technologies Polyethylene Terephthalate
In vitro studies demonstrated the Anulex technology 
was unable to with stand high physiologcially relevant 
loads. Device lacks regeneration capabiliteis. In vivo 
studies showed migration, extrusion, and unable to 
maintain disc space
2
Inclose Surgical Mesh Anulex Technologies Polyethylene Terephthalate
In vivo studies showed migration, extrusion, and 
unable to maintain disc space
2
Suture Various
Nylon, Polyester, PVDF, 
and Polypropylene.
Technically demanding due to limited space and 
potential injury to neurological structures.
1  
Single 
sutre low tensile strength.   
Disc Annular Repair 
Technology (DART) 
System
Magellan Spine 
Technologies, Inc. 
Polyetheretherketone 
(PEEK)
No studies currently published in the peer-reviewed 
medical literature to support the efficacy and safety of 
the DART system, or that it will improve health 
outcomes for use in individuals for any indication
Competitors
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expandable braided material that is preloaded on a disposable delivery tool inserted through 
the defect of the tissue, and affixed to surrounding soft tissue with the anchor bands (non-
absorbable sutures).  It is proposed as an alternative procedure for annular repair, following 
a discectomy, to re-approximate the compromised tissue of the AF.  
These devices however do not address the underlying issue of using sutures to close 
the AF. Also, sutures and these devices are fully directed to the containment of the NP, but 
they do not compensate for the loss of annulus material nor reverse the biomechanical 
changes that have occurred in the damaged AF.  
The Barricaid Device received the CE Mark approval for marketing in Europe in 
April 2009. It has thus far yet to receive FDA 510(k) clearance for marketing in the U.S. 
The Barricaid consists of a polytetrafluoroethylene (ePTFE) woven mesh supported by a 
titanium bone anchor. The function of the device is to form a mechanical barrier that closes 
the annular defect. The device is intended for use in individuals with primary IVDH with 
large annular defects. It is a commercially available implant used in adjunction to 
discectomies that fully bridges the defect in the AF.12 According to the manufacturers’ 
website, “the Barricaid enables surgeons to directly reconstruct the annulus in the region 
of the herniation.”  
The DART System received CE Mark approval for marketing in Europe in April 
2009. It has yet to receive FDA 510(k) clearance for marketing in the U.S. The device 
consists of a polyetheretherketone (PEEK) implant that provides closure of the AF. When 
implanted, it is placed near the central axis of rotation along the posterior edge of the 
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vertebral body. It is secured in place by the apophyseal ring along the vertebral body load 
column.  
DEVELOPING SCAFFOLDS FOR ANNULUS FIBROSUS TISSUE 
ENGINEERING 
Ideal AF devices used for tissue engineering is to achieve both immediate 
mechanical stability and to allow regeneration of native tissue over time. Currently, there 
is a missing link between addressing AF closure techniques and regenerative strategies. 
Closure techniques primarily focus on restoration of the mechanical integrity of the AF, 
while regenerative therapies target the engineering of healthy and functional AF tissue. 
Furthermore, closure techniques offer the clear implantation and fixation strategy; 
however, regenerative therapies lack the strategies for implantation and fixation that limits 
their clinical application.71 
To develop a suitable scaffold for tissue engineering, certain general principles 
have to be addressed including, biocompatibility, biodegradability, and method of 
delivery.116 On the microscale specific requirements for AF scaffolds include: fill and/or 
repair the AF defect to contain the NP, allow fixation to the surrounding structures (i.e. 
endplates and/or surrounding AF tissue), allow AF cells (AFCs) (or stem cells) to survive 
(differentiate/proliferate), synthesize and secrete the native ECM, have the characteristic 
anisotropic behavior to maintain/restore the mechanical properties of a spinal motion 
segment, and not irritate or adhere to the perineurium of the spinal cord.71 Table 3 
highlights the difficulties and challenges in tissue engineering seen within the cells, 
scaffolds, anatomy, and physiology.  
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Table 3: Difficulties and Challenges in Tissue Engineering of the AF Reported by 
Sharifi et. al.3  
Sources of Cells 
 Limited Sources of human cells due to the unavailability of 
healthy tissue 
 Biopsies taken from healthy AF do not contain sufficient 
cells 
 Risk of damage to AF during biopsy 
 Difficulty distinguishing inner and outer AFCs 
 Difficulties in cell culturing. Loss of cell phenotype in 2D 
cell culture and the requirement for specific media and 
culture conditions 
 Lack of suitable cell markers for AFCs 
 Poor survival of transplanted cells 
Tissue-Engineering 
Scaffolds 
 Requirement of anisotropic physical and mechanical 
characteristics mimicking the healthy AF  
 Requirements change with extent of IVD degeneration 
 Limited integration with native AF tissue 
 Confirmation to the site of implantation that hinders 
implantation and restricts implant geometry  
 Provides an aqueous medium for cell survival, while 
simultaneously maintaining mechanical properties 
 Need to promote cell attachment and provide signals for 
normal cellular activity in the AF ECM 
 Wish for radio-opacity to allow medical follow-up 
 Method of surgical implantation or injection 
Anatomy and 
Physiology 
 Avascularity of the tissue 
 Limited nutrient transport and waste disposal 
 Low healing potential 
 Low cell numbers 
 Lack of an animal model of the human degenerated IVD 
 
Overall formation of a scaffold is summarized into two classifications: single 
composition (oriented or non-oriented to mimic the organized native lamellae) or gradient 
composition to simulate internal and external layers of the AF. A gradient structure would 
have an external layer enriched in collagen type I, and an internal layer comprised of more 
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collagen type II to mimic the native structure of the AF. Several other novel suture, seal, 
and barrier techniques are currently being developed, resulting in an increasing attention 
at scientific workshops and conferences.8–15  
POTENTIAL CELL SOURCES FOR ANNULUS FIBROSUS SCAFFOLDS  
In current research, as seen in Table 4, the cells used in conjunction with the 
mechanical scaffolds include both stem cells and native AFCs.117–124 Within the native 
human AF, mature subjects have a cell density of ~9*106 cells/cm3, which is two times 
greater than the NP.125 A recent study showed that cells derived from the human AF were 
able to differentiate into the chondrogenic and adipogenic lineages.126 This suggests that 
cells in the AF could be skeletal progenitor cells that could be recruited under pathologic 
conditions such as herniation. Otherwise, progenitor cells from surrounding tissue might 
perhaps be capable of migrating into the IVD.71 However, isolation of the cells retrieved 
from a human discectomy procedure typically does not allow for division between internal 
and external AFCs.  
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Table 4: Cell Types Used for AF Repair in Current Research for AF Repair 
Type of Cells 
Porcine Annulus Fibrosus Cells 
Mesenchymal Stromal Cells (MSCs) 
Human Annulus Fibrosus Cells 
Bovine Annulus Fibrosus Cells 
Porcine chondrocytes 
Rabbit Bone Marrow-Derived MSCs (BMSCs) 
Rabbit Chondrocytes 
Bovine Annulus Fibrosus Cells 
Rat Annulus Fibrosus Cells 
Ovine Annulus Fibrosus and Nucleus Pulposus Cells 
Murine Annulus Fibrosus Cells 
Canine Annulus Fibrosus Cells 
 
INVESTIGATED SCAFFOLD DEVELOPMENT 
Abundant varieties of scaffolds have been investigated for AF tissue engineering in 
academic laboratories. With tissue engineering being a new scope of study and associated 
high development costs, AF scaffolds are being developed mostly in the academic field. 
Researchers continue to try and create a suitable AF replacement. Table 5 lists current 
materials being used with the hope of mimicking either the native AF structure and/or 
function. 
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Table 5: List of Scaffolds Investigated for AF Repair 
  Type of Scaffolds 
Biodegradable Glue (HDI-TMC1-PEG200-TMC1-HDI tissue glue) 
Alginate-based collagen shape-memory composite scaffolds 
Poly(trimethylene carbonate) (PTMC) scaffolds with an elastic poly(ester-urethane) 
(PU) membrane 
Electrospun biologic laminates 
Biodegradable shape-memory polymer network prepared by photo-crosslinking 
poly(D,L-lactide-CO-trimethylene carbonate) dimethacrylate macromers 
Expandable scaffold-free neoconstruct 
Bioactive poly(L-lactide) (PLLA/TGF) electrospun scaffold 
Biphasic whole IVD using silk protein for the AF and fibrin/hyaluronic acid gel for the 
NP 
Biphasic IVD by electrospinning using PCL as the AF and agarose as the NP 
Biphasic whole IVD using collagen 1 for the AF and alginate for the NP 
Bone marrow-derived MSC sheets and silk scaffolds 
Biphasic scaffold using demineralized bone matrix gelation (BMG) as the AF and 
elastic material based on poly(polycaprolactone triol malate) (PPCLM) as the NP 
Porous silk scaffolds 
PDLLA (poly(D-L-lactide)/Bioglass composite foam scaffold 
Alginate/chitosan hybrid fiber scaffold 
Oriented electrospun nanofibrosus scaffolds 
Biodegradable poly(1,8 octanediol malate) (POM) scaffold 
Polyglycolic acid (PGA) and calcium alginate mesh coated with 1.5% w/v polylactid 
acid  
Atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold) 
 
 In 2015, Vergroesen et al. published a research study on a biodegradable glue for 
annulus closure. The aim of the study was to investigate the feasibility and biomechanical 
properties of biodegradable glue for AF repair, using non-degenerated caprine IVDs. The 
glue consisted of a biodegradable HDI-TMC1-PEG200-TMC1-HDI tissue glue. The 
ultimate strength and endurance tests were performed using native and punctured IVDs as 
positive vs. negative controls. Results demonstrated that the biodegradable glue was able 
to provide a reduction in the risk of herniation; however, the majority of the IVDs (n=9/11) 
 26 
failed by nucleus protrusion. Before protrusion of the AF occurred the glue demonstrated 
a trend toward the partial restoration of the native AF ultimate strength. Results of the study 
showed: 1) the glue partially restores annulus integrity after a puncture, 2) increases the 
amount of force required to cause nucleus protrusion through the AF puncture occurs, and 
3) limits the number of herniation’s during ambulatory loading and ultimate strength tests. 
The use of biodegradable glue for AF repair provides a low-cost method, but the efficacy 
would need to be evaluated in long-term studies.127   
 In 2015, Guillaume et al. published a research study on enhancing AF cell migration 
in shape-memory alginate collagen composite scaffolds through in vitro and ex vivo 
assessment for IVD repair. For this study, collagen was incorporated into alginate-based 
shape-memory scaffolds. Addressed were the advantages of using alginate or collagen 
independently, in producing mechanical stability, injectability, and biological activity. In 
vitro studies demonstrated that performed alginate scaffolds promoted AF cell penetration 
and preserved the natural cell phenotype. Also, porcine AF and MSC-seeded scaffolds, 
with the incorporation of collagen, showed to have a beneficial effect on cell proliferation 
and ECM deposition. The matrix secretion was amplified by the local release of TGF-β3 
growth factor compared to those of non-supplemented media. During ex vivo experiments, 
collagen-enriched scaffolds maintained MSC viability and allowed for attachment of 
endogenous AFCs from the surrounding tissue and showed infiltration into the 3D 
constructs compared to alginate only scaffolds.128  
In 2014, Sharifi et al. published a research study on the treatment of the degenerated 
IVD through closure, repair, and regeneration of the AF. With cell-based therapies to 
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regenerate degenerated IVDs, mesenchymal stromal cells (MSCs) are more readily 
available in contrast to differentiated autologous or allogenic cells. One of the difficulties 
in cell therapy is most transplanted cells will not survive the ischemic conditions 
immediately after implantation. It was previously demonstrated with transplanted MSCs, 
80-90% died within five days after implantation in an osteochondral defect via rabbits, thus 
using MSCs for IVD treatment seems imprudent.129 Further addressed were the advantages 
and disadvantages of cell types for direct transplantation into the degenerated IVD. 
Autologous NP or AFCs do not initiate an immune response, although they are not 
available in sufficient amounts, and healthy state, their phenotype change upon expansion 
in monolayer culture, and additional surgery is required to obtain NP or AFCs with the risk 
of causing further IVDD upon harvesting. Allogeneic NP or AFCs do not initiate an 
immune response, and healthy cells are available; although, there is a limited availability 
of allogenic human NP or AFCs, and there is a risk of IVDD upon harvesting. Autologous 
stem cells elicit no immune response and are available in sufficient amounts; however, 
there presents a lack of definitive phenotype markers for NP or AFCs. Allogenic stem cells 
do not elicit an immune response and have “off the shelf” availability; although, they also 
lack definitive phenotype markers for NP or AFCs. Lastly, chondrocytes are available in 
sufficient amounts, but they have a different phenotype compared to NP or AFCs.3  
In 2014, Pirvu, et al. published a study that included a combined biomaterial and 
cellular approach for AF rupture repair. The study utilized poly(trimethylene carbonate) 
(PTMC) scaffolds seeded with bone marrow-derived MSCs in a combination with an 
elastic poly(ester-urethane) (PU) membrane. The mechanical properties of the PU 
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membrane showed an ultimate strength of 53.0 +/- 2.0 MPa, and a yield strength of 4.9 +/- 
1.4 MPa. The surfaces and cross section showed the absence of large pores and minor 
amounts of non-connected micro-porosity. Through testing it was demonstrated the PTMC 
implant combined with the sutured PU membrane restored IVD height of annulotomized 
IVDs, and prevented herniation of NP tissue into the AF defect. In comparison, press-fitted 
implants without closure were not able to withstand dynamic loading and were pressed out 
of the defect immediately after starting loading cycles. The PU membrane sutured onto the 
AF tissue was used to cover the scaffold and seal the defect. After 14 days of repetitive 
dynamic load, the sutured PU membrane retained the PTMC scaffold within the AF defect, 
and no herniation of the NP was observed. Through cellular studies, MSCs showed 
potential of positively modulating cell phenotype of native IVD tissue by up-regulating 
anabolic mechanisms and downregulating catabolic mechanisms in host IVD cells. MSCs 
were implanted into the AF defect by first embedding in fibrin hydrogel. After 14 days of 
culture, in situ, with repetitive dynamic load, the implanted MSCs remained within the 
PTMC scaffolds. This suggests that implanted MSCs can adapt their phenotype during 
culture within IVDs.130  
 In 2013, Guillaume et al. published a research study on shape-memory porous 
alginate scaffolds for regeneration of the annulus fibrosus and the effect of TGF-β3 
supplementation and oxygen culture conditions. The porous shape-memory alginate 
scaffolds were structurally based on covalently cross-linked alginate. Manual manipulation 
of the scaffolds exhibited shape-memory capability suitable for delivery in AF defects of 
the IVD through minimally invasive approaches. The scaffold was developed as a support 
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template for AF cell proliferation and tissue formation. In vitro testing demonstrated 
cytocompatibility when seeded with porcine AFCs and supported cell penetration, 
proliferation, and ECM deposition when cultured in IVD like micro-environmental 
conditions (low oxygen and low glucose concentrations) with TGF- β3 media 
supplementation. With TGF- β3, after three weeks of culture sulphated GAG (sGAG) and 
collagen type I were detected throughout the entire porous network of the alginate scaffold. 
Without TGF-β3, cells agglomerated in small clusters with limited proliferation which 
resulted in poor ECM deposition. It was also stated that cells did not appear to attach 
directly to the alginate structure itself. Guillaume believed this to be due to the low cell 
adhesion properties of alginate, and to mimic the natural orientation of collagen fibers in 
engineering scaffolds, various fabrication methods and specific architectures have been 
investigated previously. These structures could potentially be incorporated into the alginate 
solution before cross-linking to create a composite alginate-based porous scaffold with 
aligned fibers.131 
In 2013, Driscoll et al. published a research study on biaxial mechanics, and inter-
lamellar shearing of stem cell seeded electrospun angle-ply laminates for AF tissue 
engineering. The study focused on electrospun biologic laminates reaching biaxial 
properties of the native tissue. It was found that properties of the opposing (± 30°) 
constructs were significantly higher than the aligned constructs despite showing similar 
fiber stretch ratios. This could indicate that a lamellar structure with native tissue fiber 
orientation can provide higher stiffness than a single aligned fiber population, due to biaxial 
boundary conditions. It is stated that the use of biaxial testing is necessary for an 
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appreciation of this difference since previous uniaxial tensile testing showed single 
lamellar 0° constructs to be about twice as stiff as opposing constructs. This provides 
further evidence that a lamellar structure with two alternating or angle-ply fiber populations 
is an important design criterion for both native tissue and a mechanically functional 
engineered AF. The limitation of the electrospun angle-ply laminates was found to be the 
strain levels. Native AF function under large strains without failing and typical have highly 
nonlinear mechanics with large toe regions. The electrospun biologic laminates displayed 
a nonlinear response to strain, although at a lesser extent and with a smaller toe region than 
the native tissue.132  
In 2013, Sharifi et. al. published a research study on an AF closure device based on 
a biodegradable shape-memory polymer network. The biodegradable elastic polymer 
network was prepared by photo-crosslinking poly(D,L-lactide-CO-trimethylene carbonate) 
dimethacrylate macromers. The mechanical properties of the scaffold were reported in the 
range of native human AF tissue for tensile strength, elastic modulus, and elongation at 
break. The cell culture of human AFCs (HAFCs) showed good cell adhesion and 
proliferation. Cell culturing studies were evaluated on network specimens that were either 
pre-coated or not-coated with fibronectin. Fibronectin was utilized because it is previously 
reported as an ECM protein that improves cellular adhesion on a polymer surface. The 
feasibility of the shape-memory device was evaluated using a cadaveric canine model. 
Upon insertion into the IVD, the device had begun to deploy. It was reported that the 
network samples had a shape-recovery rate of 9.3% per minute when heated at a rate of 2° 
C per min. After overnight incubation at 37° C, the IVD was cross-sectioned. It was found 
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that the implant recovery to its permanent shape was not complete. This was believed to 
be due to the shape-recovery force of 1 MPa not being larger than the force exerted by the 
surrounding AF tissue on the implant. Also, through manually applied flexion and 
extension forces, and axial rotations the implants dislodged from their original positions. 
Thus, it is necessary for an improvement in the design of the implant to increase the 
mechanical properties needed to withstand native forces.133  
In 2013, Cho et al. published a research study on the construction of a tissue-
engineered AF. In this study, they characterized an expandable scaffold-free neoconstruct 
using autologous AFCs. The construct was prepared from pellet cultures, derived from 
monolayer cultures of AFCs from mature pigs, until the cells had reestablished a 
proteoglycan rich cell associated matrix. The second step consisted of the removal of the 
cells embedded in their own ECM products as a membrane from culture plates and 
subsequent maintenance as a detached explant tissue. This method consisted of using only 
the matrix produced by the cells themselves and does not require the use of exogenous 
matrices. The collagen content and biomechanical properties after three weeks of culturing 
was similar to that found in mature porcine AF tissue. The principle advantages of these 
constructs observed were the artificial materials are not required to obtain a sizable 3D AF 
tissue construct, and the cell distribution was uniform. This contrast could provide 
applications for analysis of cell behavior as it provides a well-defined 3D environment for 
studies of biomechanical load or growth-factor stimulation.134  
In 2012, Vadala et al. published a research study on bioactive electrospun scaffolds 
for AF repair and regeneration. The scaffold was synthesized by electrospinning, with a 
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direct incorporation of TGF-β1 into the polymeric solution. The scaffold was a poly(L-
lactide) (PLLA/TGF) electrospun scaffold. The electrospun scaffold consisted of a non-
woven porous mesh with randomly oriented fibers. The study demonstrated a sustained 
release of growth factors and inducement of anabolic stimulus on bovine AFCs while 
mimicking the ECM three-dimensional environment of the AF tissue.135 
 In 2012, Chan et al. published a research study on IVD regeneration or repair with 
biomaterials and stem cell therapy, and if it is feasible or fiction. They describe how 
commercially available implants for closing the AF reinforces the complete posterior 
annulus and could prevent contralateral herniation. Although, these devices are unable to 
maintain the biological AF structure in the long-term or stop AF degeneration. Tissue 
engineering methods aim to close the injured AF to prevent IVDH as well as to stop the 
AF from further degeneration. They also identified the previously attempted engineering 
approaches, such as hydrogels, alginate, PDLLA/Bioglass, silk, and electrospinning 
discussed further in this paper. Additionally, a whole IVD tissue engineered total disc 
replacement was addressed: A biphasic whole IVD using silk protein for the AF and 
fibrin/hyaluronic acid gel for the NP using porcine AFCs and chondrocytes respectively. 
Another approach described was a fabricated biphasic IVD by electrospinning using PCL 
as the AF and agarose as the NP. Lastly, the last approach addressed was a biphasic whole 
IVD using collagen 1 for the AF and alginate for the NP. An issue they address is the major 
challenge of not de-differentiating cells in culture after in vitro culture. With primary cells 
starting to dedifferentiate when they are cultured in vitro over long passaging (p>6), 
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strategies are needed to control the state of the cells to ensure these cells are not de-
differentiated over long expansion time and remain suitable for IVD tissue engineering.136  
In 2012, See et al. published a research study on simulated IVD-like assembly using 
bone marrow-derived MSC sheets and silk scaffolds for AF regeneration. The structure 
used to form the IVD-like assembly was constructed of a cylindrical silicone NP substitute. 
The study addressed the potential to regenerate the AF by using rabbit bone marrow-
derived MSCs (BMSCs) to form cell sheets and incorporating them onto silk scaffolds. 
The study demonstrated that BMSC cell sheets can be successfully transplanted and adhere 
well when combined with silk scaffolds. The cells within the assembly remained viable 
and showed the presence of GAGs throughout the ECM. Through immunohistochemical 
(IHC) staining, collagen type I and II were present and the composition of type II increased 
from 8% to 70% over a four week culture. This could prove this method has potential to 
regenerate ECM similar to that of the internal AF. One shortfall of the study was no specific 
markers or genes to are known to differentiate the IVD cells from other lineage-specific 
cells. However, due to the lack of specific markers, studies have only reported that the 
internal and external AF have a gene expression profile and ECM that resembles those 
synthesized by articular chondrocytes and fibroblasts, respectively.137 
In 2008, Wan et al. published a research study on a biphasic scaffold for AF tissue 
regeneration. In this study, a biphasic scaffold was used to simulate the annulus both 
structurally and elastically. They describe the generation of a cylindrically shaped 
composite implant designed to emulate the AF. The outer phase of the scaffold consisted 
of demineralized bone matrix gelation (BMG). The inner phase of the scaffold was 
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constructed of an elastic material based on poly(polycaprolactone triol malate) (PPCLM). 
The BMG phase was used to increase the mechanical strength and to simulate the 
ligamentous structure of the outer AF. The PPCLM phase was seeded with rabbit 
chondrocytes that showed proliferation and ability to maintain their phenotype with a four 
week culture.123  
In 2008, Chang et al. published a research study on enhancing AF tissue formation 
in porous silk scaffolds. This study was an extension to their previous publication, “Porous 
Silk Scaffolds to be used for Tissue Engineering.” The aim of this study was to determine 
whether dynamic culture and/or scaffold pore size would influence AF tissue formation 
and distribution in silk scaffolds in vitro. It was shown that scaffolds with an average 600 
μm pore size appeared to be the best model to mimic the native AF. Scaffolds were seeded 
and grown in either static culture or spinner flasks (90 rpm). After two weeks, scaffolds in 
the dynamic culture showed greater than 3-fold increases in collagen accumulation per cell 
compared to static cultures, and a 1.5-fold increase per cell in proteoglycan accumulation. 
The tissue generated under dynamic conditions also appeared to be more cellular as the 
DNA content was significantly greater compared to static cultures. However, in both the 
static culture and spinner flasks the scaffolds had a similar pattern of tissue distribution as 
more tissue was present on the outer surface, with little tissue formation on the interior of 
the scaffold.138  
In 2008, Helen et al. published a research study on cell viability, proliferation, and 
ECM production of HAFCs cultured within PDLLA/Bioglass composite foam scaffold in 
vitro. The scaffolds were comprised of poly(D, L-lactide) (PDLLA)/Bioglass. The PDLLA 
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composite foams were combined with varying percentages (0, 5, and 30 wt.%) of Bioglass 
through thermally induced phase separation (TIPS), and characterized by scanning electron 
microscopy (SEM). HAFCs were used to determine viability, cell attachment, 
proliferation, and proteoglycan/collagen production. Live/dead staining showed viable 
HAFCs were present on the top surface of the foams as well as penetrating into the internal 
pore structure. SEM observations revealed larger quantities of clusters of HAFCs were 
attached to the pore walls to the foams with 5 and 30 wt.% Bioglass in comparison to the 
0 wt.% Bioglass. DMMB assays showed HAFCs cultured within the PDLLA/30BG foam 
had a greater ability to deposit collagen and proteoglycan after four weeks of culture 
compared to lower wt.% Bioglass. IHC analysis of collagen production demonstrated that 
collagen produced in all cultures was predominantly type I collagen, similar to collagen 
found in the external AF.122  
In 2007, Chang et al. published a research study on porous silk scaffolds to be used 
for tissue engineering. The biomaterial used was a protein polymer made by silkworms, 
silk fibroin. The idea that the use of a silk scaffold would potentially degrade at a 
sufficiently slow rate would allow for proper tissue development, and could be covalently 
coupled to peptides to allow for the potential of enhancing cell attachment. The results of 
the study demonstrated that AFCs adhered to porous silk scaffolds and synthesized 
collagen and proteoglycans after attachment: with a 10-fold increase in collagen deposition 
and a small increase in proteoglycan content. After 24 hours, 35% cells seeded into the 
scaffold had attached, but only a significant increase in cellularity was observed on day 56. 
However, with the coupling of RGD-peptides, there was no evidence of further cell 
 36 
attachment, collagen accumulation, or tissue formation. RGD decoration showed to have 
no effect on cell seeding efficiency or morphology. The silk fibroin scaffold was found to 
be a suitable scaffold material for AF tissue engineering; however,  it was observed that 
tissue growth was limited and not uniformly distributed throughout the scaffold.118  
In 2007, Shao et al. published a research study on developing an alginate/chitosan 
hybrid fiber scaffold for AFCs. The study utilized a fibrous scaffold made of alginate or 
alginate/chitosan created by wet-spinning and lyophilization. Demonstrated through 
testing, alginate/chitosan hybrid scaffolds exhibited a slower degradation rate than pure 
alginate fiber scaffolds while both scaffold types did not display any cytotoxicity to 3T3 
fibroblasts and could maintain canine AFC growth. Cellular studies showed AFCs retained 
their spherical shape within the fibrous scaffold at the beginning of the culture period and 
formed into cell aggregates at later time points. ECM molecules, including collagen I and 
II, aggrecan deposition were also detected in the AFC clusters.117  
In 2007, Nerurkar et al. published a research study on the mechanics of oriented 
electrospun nanofibrous scaffolds for AF tissue engineering. The study utilized electrospun 
poly-ε-caprolactone nanofibrous polymer scaffolds. Bovine AFCs were seeded onto the 
scaffolds, and biochemical analysis was performed on days 1, 14, 28. The model was used 
in contrast against single lamellae of the native internal and external regions of the AF. 
Results demonstrated elongated cells aligned along the predominant fibers direction with 
proteoglycan (s-GAG) and collagen content increase over the four week culture. Uniaxial 
tension mechanical testing was performed on various fiber angles of the scaffold: 0°, 15°, 
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30°, 45°, and 90°, and showed that moduli varied nonlinearly between the different fiber 
angles. A nonlinear decrease in modulus was seen with increasing fiber angles.120  
In 2007, Wan et al. published a research study on a novel biodegradable poly(1,8 
octanediol malate) for AF regeneration. The scaffold was formed using malic acid-based 
polyester poly(1,8 octanediol malate) (POM), which was synthesized by direct 
polycondensation. Tensile strength, compressive stress, and compressive Young’s 
modulus of POM demonstrated an increase with the extension of the polymerization time 
of POM. However, degradation rates and elongations of POM decreased with extensive 
polymerization of POM. Rat AFCs were seeded onto the scaffold and showed that AFCs 
did not attach readily to the polymer after polymerization times less than two days. Rat 
AFCs were then cultured in monolayers for 1, 2, and 4 days. As time points increased, 
proliferation of cells with stellate and elongated morphology was seen, with an increase in 
gene expression for aggrecan and type II collagen only seen on day 4.121  
In 2007, Wan et al. published a research study on a biphasic scaffold for AF tissue 
regeneration. They created a biphasic elastic scaffold comprised of an inner and outer phase 
sections. The outer phase was a ring-shaped demineralized BMG extracted from cortical 
bone. The BMG was studied due to its ECM composition of mainly type I collagen, its 
natural biomechanical properties, and because it contains insoluble bone morphogenetic 
proteins, non-collagenous proteins, and intrinsic growth factors. The inner phase was a bio-
biomaterial poly(polycaprolactone triol malate) (PPCLM) orientated in concentric sheets 
and seeded with chondrocytes. Mechanical testing was conducted on the scaffold to test 
for the incorporation of BGM into the PPCLM scaffold. Through testing, it was found that 
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mechanical properties and degradation of PPCLM could be adjusted by controlling the 
post-polymerization time of the pre-polymer. Mechanical testing results demonstrated 
good biocompatibility in foreign body response in vivo assay, enhanced compressive 
strength and 50-fold greater tensile stress. Rabbit chondrocytes were seeded onto the 
scaffold and showed proliferation and penetration into the inner phase after four weeks. 
Production of type II collagen and aggrecan was detected in both phases of the scaffold.123 
In 2006, Helen et al. published a research study on the potential use of 
PDLLA/45S5 (PDLLA-poly(D-L-lactide))/Bioglass composite films for the culture of 
AFCs in vitro. The study evaluated the attachment and matrix production of bovine AFCs 
to four different substrates. They chose to combine bioactive glass with degradable 
polymers due to the ion dissolution products of the bioactive ceramic counteract the acidic 
degradation products of the polymer to reduce the inflammatory response. Through SEM 
analysis it was shown that cells had attached and spread on all films after three days and 
had proliferated to form a confluent monolayer of cells by day 7. sGAG production was 
measured, and shown that PDLLA/30BG had enhanced sGAG production after three 
weeks; although, after four weeks in cultures sGAG production decreased. The results of 
the study showed that PDLLA/Bioglass provided an appropriate substrate for AFCs and 
that these films promote the production of an ECM containing abundant sGAG and 
collagenous proteins.139  
In 2004, Mizuno et al. published a research study on tissue-engineered composites 
of the AF and NP for IVD replacement. The study used a polyglycolic acid (PGA) and 
calcium alginate mesh coated with 1.5% w/v polylactic acid solution. AF and NP ovine 
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cells were seeded onto PGA and alginate scaffolds to create a tissue with AF and NP 
components.  Based on histologic and biochemical characteristics of the tissue-engineered 
IVDs, they presented similar to those of native IVDs based on morphology and quantities 
of collagen and proteoglycans produced. DNA content remained constant during first eight 
weeks but increased greatly between 12-16 weeks in vivo. Amounts of hydroxyproline and 
GAG increased with time with GAG reaching native tissue levels after 16 weeks.119  
In 2002 and 2003, Sato et al. published research studies on an atelocollagen 
honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold) and the 
regeneration of the IVD with an allograft of cultured AFCs. During manufacturing, it was 
found the diameter of the pores could be controlled by changing the concentration of 
collagen solution and ammonia gas. The first study demonstrated stability, 
cytocompatibility, uniform seeding of cells, and accumulation of produced matrix 
components within the ACHMS-scaffold. The objective of the second study was to 
investigate the regeneration of IVDs after laser discectomy using their tissue engineering 
methods. They used AFCs isolated from Japanese white rabbits and seeded them onto the 
ACHMS-scaffold for one week. They then implanted the scaffold into the lacunas of an 
IVDs of recipient rabbits that had the NP vaporized by a laser. Results demonstrated cells 
proliferated and retained spherical shape, higher increases in type II collagen and GAG 
content than compared to monolayer content, and a presence of accumulation of cartilage-
like matrix after insertion.124,140 
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TISSUE ENGINEERING AND REGENERATIVE MEDICINE 
Tissue engineering evolved from the field of biomaterials and refers to the 
combination of scaffolds, cells, and suitable biochemical and physicochemical factors to 
form functional tissues to improve/replace biological functions. There is a need to create 
an effective AF repair device with could improve patient outcomes and reduce healthcare 
costs while preventing re-herniation and the need for spinal fusion for patients with IVDH 
and IVDD, respectively. Regeneration of the damaged AF is an appealing concept since it 
permits restoration of all functions of the AF; however, this concept is exceptionally 
complex to attain.  It must be able to endure the direct mechanical strength applied and be 
a size sustainable to contain the NP.141 The progression in development needed for the 
success of regenerative strategies of the AF consists of three major components: cell 
therapy, gene therapy, and scaffolds.63 Proclaimed in a recent study, the ideal strategy for 
IVD regeneration is to restore the function and integrity of the IVD by using biomaterials, 
native matrices, growth factors, and cells that produce matrices; although, with the complex 
biological, mechanical environment of the IVD makes the synthesis of an artificial IVD a 
difficult task.85 However, while a difficult task, without a functional AF repair device to 
resist expulsion of NP tissue and the IDP, generated within, IVD regeneration and 
prevention of IVDD and IVDH is deemed to fail.  
During the early 2000’s there was an increase in research of NP replacements with 
the goal of restoration of the physiological IDP and IVD disc height. However, there was 
a lack of effective strategies that combated the damaged AF (incurred via implantation of 
such devices or the pathological processes). Current strategies for NP replacements attempt 
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to restore native NP mechanical properties, but do not address the issue of the inferior 
quality of the surrounding AF, which is not capable of withstanding IDP.71 Recently in 
research, IVD engineering strategies are increasingly focusing on the regeneration or repair 
of the AF in order to reduce the number of re-herniation’s, increase the potential of NP 
engineering strategies, and to mechanically assist NP replacement therapies.141,142  
An effective AF closure/repair device in conjunction with a less aggressive 
discectomy for IVDH and/or NP arthroplasty for IVDD, may result in improving patient 
outcomes, decreased pain, and provide fewer revision surgeries via lower re-herniation and 
expulsion rates.5,6 In either case, an intact AF must be re-established to prevent implant 
expulsion or re-herniation, thus addressing the two major spinal pathologies directly 
associated with an IVD. Therefore, it would be advantageous to develop a biomimetic 
patch for biological augment AF repair to help mitigate this re-herniation.  
The objectives of this research were to investigate the development of a biomimetic 
patch for biological augment AF repair through: (1) characterizing the micro-architecture 
of the multi-laminate angle-ply AF patch, (2) evaluating the mechanical properties of the 
developed multi-laminate angle-ply AF patch, and (3) evaluating the cytocompatibility of 
the multi-laminate angle-ply AF patch. 
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CHAPTER II 
MATERIALS & METHODS 
 
SPECIMEN PROCUREMENT, DISSECTION, AND TREATMENT 
Porcine hearts were obtained at time of slaughter from a local abattoir. The parietal 
layer of the pericardium was separated from the heart, and excess adipose fatty tissue and 
connective tissue were removed by manual separation using tweezers and scalpel blades. 
The parietal pericardium layer was chosen due to its natural structure. The parietal 
pericardium is fused to and inseparable from the fibrous pericardium (most superficial 
layer of the pericardium). It consists of dense and loose connective tissue containing 
collagen type I.143 The dense connective tissue is divided into regular and irregular sections. 
Dense regular connective tissue contains collagen fibers bundled in a linear/parallel 
orientation. The presence of these collagen fibers were utilized during fabrication of the 
scaffold. The decellularization procedure was adapted and modified from methods 
described by Teeder et al without elastase treatment.144 
FABRICATION OF BIOLOGICAL COLLAGEN ANGLE-PLY SCAFFOLD 
Multi-laminar angle-ply collagen patches were designed to mimic the native 
architecture of the AF. Angle-ply patches consisted of multiple layers of pericardium tissue 
adhered together via a sewing machine, backing material, and suture thread (Rachel 
Reference if previously reported). Single layers of pericardium were placed on a light box 
to determine the preferred direction of the collagen fibers. The layers were then stacked 
one on top of the other at ± 30° alternations to create the native angle-ply formation 
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(Figure 7). For sewing, the layers were placed on top of a water-soluble backing material 
(solvy-ultra). The backing tissue was necessary during sewing to provide even positioning, 
and to permit the needle to puncture all the layers of the pericardium. Dimensions of 8 x 8 
mm2 were sewn into the layers to create the multi-laminar angle-ply patch. The backing 
material was then removed manually by hand/tweezers, and stored in ddH2O for 4 hours to 
ensure complete degradation from the patch. The dimensions of a three layer patch are: 
length (8 mm), height (8 mm), and width/thickness (0.8 mm).  
ISOLATION AND EXPANSION OF BOVINE AF CELLS 
Three bovine tails from young calves were obtained at time of slaughter from a 
local abattoir. The caudal discs were separated using mechanical shears, and the NP was 
removed first through a 6mm biopsy punch in order to ensure harvest of only the AF. The 
AF tissue was then removed and minced using two scalpel blades. The tissue was then 
transferred to a 50 ml conical tube with 25 ml of collagenase solution (1% Ab/Am, 0.2% 
Collagenase Type I (125 units/mg dry weight) and DMEM). Following tissue digestion 
overnight (~18 hours) at 37°C, the solution was centrifuged at 1000 rpms for 5 minutes. 
The supernatant was removed and the cells were re-suspended in cell culture media (1% 
Ab/Am, 10% FBS and DMEM). Passage 2 (P2) bovine AF cells were used in the current 
study.  
CELLULAR ANALYSIS 
Cellular studies were conducted on the multi-laminar angle-ply AF patch to ensure 
cell viability on all layers of the patch. Previous laboratory testing showed that bovine 
AFCs were viable on the surfaces of the patches through day 15 studies; however, cell 
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viability between the upper and lower layers was unattainable. Multiple variations of tissue 
disruption modifications were used with the hypothesis of degrading the tissue matrix to 
provide more nutrients to the inner layers. For all studies, patches were prepared by re-
sterilization and neutralization before cell seeding. Sterilization occurred by placing the 
patches in a specimen cup with 100 ml of 0.1% Peracetic Acid on a shaker at room 
temperature for two hours with a speed of 150 rpms. The patches were then washed in 100 
ml of sterile PBS for 1 hour (3x) on a shaker at room temperature for one hour with a speed 
of 150 rpms. The patches were then neutralized in 100 ml of sterile 50% fetal bovine serum 
(FBS)/ 48 % Dulbecco’s Modified Eagle Medium (DMEM) + 2% antibiotic/antimitotic 
(Ab/Am) overnight on a shaker at room temperature with a speed of 150 rpms. The tissue 
disruption performed and discussed herein was sonication of the tissue. Pericardium tissue 
was placed in a Sonicator for 20 minutes prior to patch fabrication. Sonication affected the 
tissue by pressure created through a probe which rapidly expands and contracts at high 
frequencies. The high frequency oscillation is due to the piezoelectric effect, with rapid 
oscillation of the current causing tiny shock waves.145  
AF CELL SEEDING ONTO SCAFFOLD 
Following sterilization and neutralization, patches were divided into 2 separate 
groups: control and sonicated. 5 x 106 cultured bovine AF cells at passage 2 (P2) were 
placed in a predetermined amount of cell culture media. Previous studies not shown herein, 
determined the optimized volume amount to prevent run-off of the patch. 6 x 105 cells were 
seeded per patch (16 x 103 cells per mm2): 2 x 105 cells were seeded in 40 μl of CCM onto 
the top the patches, 2 x 105 cells seeded in 75 μl of CCM were injected into the middle 
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layers using an 18 gauge needle. The patches were then incubated at 37°C for four hours 
for cell attachment. After incubation, the patches were flipped using sterile tweezers, and 
the same process was completed for seeding 2 x 105 cells in 40 µl of CCM onto the bottom 
of the patch.  
STAINING HISTOLOGY 
Representative samples of single layer decellularized pericardium were aligned in 
alternating degrees to illustrate the articulation of the alternation of fibers within 
pericardium tissue. This was performed with the intent to mimic the native angle-ply 
foundation of the human AF. Patches were fabricated as stated above, in ± 30° and + 30° 
alternations. The samples were then analyzed via histological analysis. Representative 
samples were placed in histological cassettes with gauze to hold the sample in place and to 
prevent swelling between the layers. The samples were then fixed in neutral buffered 
formalin for 24 hours, embedded with paraffin wax, and sectioned at 5 μm thickness. 
Hematoxylin and Eosin (H&E) staining was performed to visualize cellular material and 
tissue extracellular matrix. Masson’s trichrome staining was used to define the composition 
of the pericardium tissue, and to verify the angle-ply alternation between the layers. A Zeiss 
Axio Vert.A1 camera microscope with AxioVision SE64 Rel. 4.9.1 software was using for 
imaging and reviewing of the histological slides. 
BIOMECHANICAL EVALUATION OF MULTI-LAMINATE AF PATCH 
ULTIMATE TENSILE STRENGTH 
Mechanical tensile testing was performed on decellularized single and multi-
laminar angle-ply AF patches to ensure comparable tensile ultimate tensile strength (UTS) 
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to native human AF tissue. This is deemed crucial to ensure the patch does not disrupt the 
function of the native tissue, and is able to withstand the max tensional force experienced 
during extension and flexion. The representative samples for the decellularized single layer 
pericardium were tested in a fiber preferred (tension applied parallel to collagen fibers; 
n=5) and cross-fiber direction (tension applied perpendicular to collagen fibers; n=5). 
Representative samples of three layered multi-laminar angle-ply AF patches were also 
tested (tension applied at ± 30° alternating angles of patch aligned to the vertical axis; 
n=5). The tensile testing protocol was adapted from methods describing single human AF 
lamellae tensile testing by Green et. al.101 
Testing was performed on a mechanical testing system (MTS) Synergie-100 fitted 
with a 100 N load cell. Samples were preheated to 37°C in a water bath for 30 minutes prior 
to testing and sample length, width, and thickness were determined using digital calipers. 
Samples were placed in tensile grips lined with fine-grit sandpaper to the ends of each 
sample before insertion into the MTS clamps to prevent slippage. Once samples were 
secured, preconditioning (5 cycles to 10% stain at 10 mm/min), and testing to failure at a 
rate of 240 mm/min was performed. Stress strain data was recorded, plotted, and collected 
for statistical analysis. The tensile elastic modulus was determined from the linear region 
of the graph. The UTS was determined by dividing the max peak load by the cross-sectional 
area of the sample.  
PATCH IMPACT RESISTANCE 
Impact strength was determined in accordance with ASTM D1709 with minor 
modification. Representative samples of multi-laminar angle-ply AF patches of 1, 2, 3 and 
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6 layers were tested (n=4 per group). The impact mechanical test was performed to obtain 
the minimum number of layers required to withstand the changes of IDP of the IVD. 
Understanding the impact force is crucial due to high rapid changes in IDP which could 
result in herniation’s of weaken or damaged areas of the IVD. The impact force was 
determined using a custom design sled fixture consisting of four rails attached to a base 
platform, with a free-moving apex platform. The testing apparatus for the tissue consisted 
of two wooden blocks bolted together with a 6.25 mm diameter hole drilled through the 
center of both blocks. On the inner surface of each block a neoprene square glued down 
with epoxy along with a layer of sandpaper to prevent the samples from slipping during 
testing. The representative samples were centered over the hole in the block and bolted 
together. A 6 mm steel ball and rod was slid through the top block and placed in contact 
with the tissue. The remaining rod extruded from the wooden block towards the apex of 
the apparatus. Concisely, various weights ranging from 0.18-0.58 kg were dropped from a 
consistent height of 10 in (0.254m) towards the base of the platform along the four rails. 
The impact between the weight of the free-moving apex platform and rod were used to 
measure the amount of force the patch could withstand.  
Using the application of conservation of energy of a falling object EQ 1, the impact 
velocity and kinetic energy were calculated. Thus, combined with the distance traveled, 
impact force [N] was calculated. In conjunction to the impact force data, the contact radius 
between the ball and patch was needed in order to convert to pressure. The law of 
conservation of energy and the following formulas were used to calculate the contact 
radius:  
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Figure 6: Method of Maximum Pressure Calculations. A sphere on a flat plate (a 
flat plate is a sphere with an infinitely large radius).146  
 
This formula represents the calculated contact surface [m] of the ball with the 
pericardium. F is the load [N] of the force exerted on the patch at the time of impact. R1 
and R2 were the radius [m] of the ball (3 mm) and the patch (∞) respectively, where the 
patch was considered a sphere with an infinitely large radius. E1 and E2 were the elastic 
modulus [Pa] of the ball (200 GPa) and the patch (16.4 MPa, determined from tensile 
testing), respectively. Poisson’s ratios, 𝜐1 and 𝜐2, of the ball (0.27) and the pericardium 
(0.3), respectively.7–9 Potential Energy (PE) and kinetic energy (KE) were used based on 
the conservation of energy calculation to determine the impact force of a falling object. 
Impact force was then converted to pressure [Pa] to relate to IDP changes (EQ. 3). The data 
was collected and recorded for statistical analysis. 
TENSILE FATIGUE TESTING 
Mechanical tensile fatigue testing was performed on three layered multi-laminar 
angle-ply patches to test the ability of the angle-ply patch to withstand 10,000 cycles of the 
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UTS of the native AF tissue. The testing setup was in reference to previous fatigue testing 
of Green et. al.101 Testing was conducted on a Bose ElectroForce 3200 series, model: 3220, 
WinTest 7 (software), with a 100 lb. load cell. Representative samples were preheated to 
37°C in a water bath for 30 minutes prior to testing and sample length, width, and thickness 
were determined using digital calipers. The samples were then attached by two U-shaped 
clamps with fine-grit sandpaper to prevent slippage of the material. The clamps were 
submerged in a bath chamber filled with sterile PBS solution and protease inhibitor. Once 
the samples were in place, the sample was aligned and brought taught to have a minimum 
of 0.5 N load on the tissue prior to testing. Once the sample was secured, preconditioning 
(5 cycles at 10% strain of the gauge length) was performed. Following preconditioning, 
the base plate was adjusted to apply a minimum of 0.5 N load to the sample. Axial tensile 
force was then applied on the patch (tension applied with alternating angles of ± 30° 
oriented in the vertical axis; n=16) at a pre-determined load [N] based on the representative 
percentage of UTS. Testing frequency was set at 0.5 Hz, and samples were ran until 
structural failure, or completion of 10,000 cycles. One cycle consisted of raising to the 
predetermined testing load with sample in tension, and lowering back down to the original 
testing load. The displacement, load control value, total time, cycles performed, and where 
the sample broke were recorded for statistical data analysis.  
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STATISTICAL ANALYSIS 
Statistical analysis of the data were performed using Microsoft Excel or statistical 
analysis software (SAS Enterprise Edition 3.4, Version 9.4 or above). Results are 
represented as mean ± standard error of the mean Data was analyzed using a one-way 
ANOVA or by a two-tailed Student’s t-test of unequal variance with significance defined 
as (p < 0.05).  
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CHAPTER III 
RESULTS 
 
PERICARDIUM SHEET FIBER ALIGNMENT AND AF PATCH ASSEMBLY 
Our group has previously confirmed the decellularization of porcine pericardium 
via immunohistochemistry, agarose gel electrophoresis and Nanodrop analysis 
demonstrating the complete removal of alpha-Gal (porcine antigenic epitope), and a 95.3% 
decrease in DNA as compared to the fresh porcine pericardium, respectively.147 This 
decellularization method was utilized before construction of AF patches.   
Macroscopically, parietal pericardium sheets demonstrated a fiber preferred 
direction that was evident when the tissue was placed over a light box (Figure 7A). 
Histology of individual decellularized pericardium sheets confirmed the composition of 
the tissue (Figure 8A-B): dense regular collagen connective tissue (dense collagen type I 
fibers bundled and aligned in a parallel orientation, left) fused with dense irregular collagen 
connective tissue (dense arrangement of thick collagen type I fibers embedded in an 
amorphous ground substance, right). The average thickness of single-ply sheets of 
decellularized pericardium was 0.026 ± 0.002 mm.  
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Figure 7: Fabrication of the AF patch through the alternation of individual sheets 
with collagen fibers oriented at ± 30° to a common horizontal axis. A) Representative 
image of a single piece of porcine pericardium. Arrows indicate collagen fiber 
preferred direction within each pericardium layer, and boxes (dotted outline) 
represent regions cut out for use in AF patches. B) Representative image of a 3-layer 
AF patch (5 [L] x 5 [W] x 0.8 [T] mm) following patch fabrication methods. C) 
Schematic representation depicting the fiber alignment in individual decellularized 
porcine pericardium sheets, subsequent stacking, and suturing of sheets together.  
Multi-laminate patches comprised of 2, 3, 4, and 6 layers were successfully 
assembled having an average thickness of 0.05 ± 0.004 mm, 0.08 ± 0.006 mm, 0.11 mm 
± 0.009 mm, and 0.16 ± 0.02 mm, respectively. The average length and width of multi-
laminate patches for mechanical testing and cellular studies were 12 x 12 mm and 7 x 7 
mm, respectively. Predetermined by testing protocols, different patch dimensions were 
constructed to fit into different test apparati. Patch sizes ranging from 4 x 4 mm to 30 x 30 
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mm were produced using our assembly method. Patches were assembled to mimic the 
human AF architecture with the multi-laminate sheets of porcine parietal pericardium 
aligned sequentially in alternating ± 30° to a common horizontal axis using a light box and 
secured by suture (Figure 7C).  
CONFIRMATION OF ANGLE-PLY ARCHITECTURE 
Composition and microstructure of the AF dictate its mechanical function. Based 
on the organization of collagen fibers between subsequent lamellae dictates the amount of 
intradiscal pressure the AF is capable of resisting. Therefore, to develop a biomimetic 
biomaterial mimicking the native AF, the resulting AF patch must be capable of presenting 
fiber alignment similar to the native tissue. To evaluate the capability of aligning porcine 
pericardium in alternating fiber alignment, polarized light microscopy and histology was 
used to confirm the orientation of the fiber preferred direction within each layer of the 
multi-laminate AF patches. Figure 8C illustrates the proof of concept demonstrating the 
successful construction of a 3-layered angle-ply patch with aligned collagen fibers 
orientations with the collagen fiber preferred direction running parallel to the viewer. While 
the proof of concept demonstrating the alternations of individual layers was demonstrated 
with the middle layer collagen fibers running parallel to the viewer, and the outer layer(s) 
collagen fibers aligned coming towards the viewer. (Figure 8D).  
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Figure 8: Histological analysis of decellularized porcine pericardium stained with 
Masson’s trichrome (blue = collagen, red = cytoplasm), (arrow = fiber direction). 
A&B) Representative single layer pericardium illustrating dense regular connective 
tissue (X) and dense irregular connective tissue regions ( ), (magnification: 100X and 
200X, respectively). C&D) Histological image depicting the ability to alternate the 
fiber preferred orientation in additional pericardium sheets. Decellularized 
pericardial sheets were aligned based on alternating the angle of the fiber-preferred 
direction between each sequential layer (arrows indicate collagen fiber preferred 
direction within each pericardium layer), (magnification: 100X). [C] All three layers 
orientated with the collagen fiber preferred direction running parallel to the viewer, 
while [D] illustrates the alternation of fiber preferred direction with the middle layer 
 
X 
X 
X X 
X X 
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collagen fibers running parallel to the viewer, and the outer layer(s) collagen fibers 
aligned coming towards the viewer.  
 
ULTIMATE TENSILE STRENGTH 
To determine the ultimate tensile strength (UTS) and elastic modulus (EM) of the 
AF patch and to understand how fiber alignment impacts these properties, static tensile 
testing was performed on 3-layered multi-laminate AF patches, as well as, single layer 
sheets of pericardium.  Single layer pericardium was tested in the fiber preferred (tensile 
load applied parallel to collagen fiber) and cross-fiber (tensile load applied perpendicular 
to collagen fiber) directions. Average UTS of a 3-layer AF patch, single layer fiber 
preferred, and single layer cross-fiber testing were 5.9 ± 0.3 MPa, 5.6 ± 1.1 MPa, and 2.9 
± 0.2 MPa, respectively (Figure 9). A statistical difference (p < 0.05) was found between 
the UTS of three layered patches and single layer tissue oriented in the cross-fiber direction. 
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Figure 9: Tensile UTS of decellularized single layer sheets and 3-layered AF patches 
were tested, and values were compared to human AF (Dotted horizontal line indicates 
measured human AF UTS reported in literature).101 The representative graph 
illustrates the average UTS for a 3 layered AF patch and single layer sheets aligned 
in fiber preferred and cross fiber directions. * indicates significant difference (p < 
0.05). 
EM was calculated from the linear region of the stress vs. strain graphs. Average 
EM of a 3-layer AF patch, single layer fiber preferred, and single layer cross fiber were 
16.4 ± 3.5 MPa, 62.0 ± 13.6 MPa, and 23.6 ± 6.0 MPa, respectively (Figure 10). A 
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statistical difference (p < 0.05) was found between the EM of 3-layered patches and single 
layer tissue oriented in the fiber preferred direction. 
 
Figure 10: Tensile EM of decellularized single layer sheets and 3-layered AF patches 
were tested, and values were compared to human AF lamellae (Dotted horizontal line 
indicates measured human AF tensile modulus range reported in literature).102 The 
representative graph illustrates the average tensile EM calculated from the linear 
region of the graph for decellularized 3 layered patch and single layer sheets aligned 
in fiber preferred and cross fiber directions. * indicates significant difference (p < 
0.05).  
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AF PATCH RESISTANCE TO INSTANTANEOUS CHANGES OF 
INTRADISCAL PRESSURE 
One of the primary mechanical functions of the AF is to resist the IDP generated 
by the NP. The IDP can change (increase) abruptly due to daily activities causing NP to 
herniate from native AF. Thus the ability of the AF patch to resist bursting open from a 
sudden increase in impact force/pressure was evaluated. The mechanical evaluation of 
instantaneous change of IDP for 1-layer, 2-layer, 3-layer, and 6-layer multi-laminar patches 
demonstrated an average impact resistance of < 6.81 MPa, 6.8 ± 0.0 MPa, 7.99 ± 0.22 MPa, 
and 9.94 ± 0.98 MPa, respectively (Figure 11). Single layer pericardium sheet impact 
resistance occurred at < 6.81 MPa, the lowest measureable amount of the custom designed 
testing apparatus. A linear increase in average impact pressure was observed with 
increasing layers included in the patch. Statistical difference (p < 0.05) was observed 
between 2-layer and 6-layer patches, and between 3-layer and 6-layer patches.  
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Figure 11: Impact resistance testing indicates multi-laminate AF patches can 
withstand instantaneous application of intradiscal pressure commonly experienced in 
the IVD. Representative graph of the average maximum calculated impact pressure 
withstood by a 2-, 3-, and 6-layer patches. (Dotted horizontal line indicates highest 
measured in vivo human IDP reported in literature [2.3 MPa observed while bent 
over with a round back while lifting 20 kg.]) * indicates significant difference (p < 
0.05). 
Previous testing conducted in our lab was conducted to determine the quasi-static burst 
strength of AF multi-laminate patches.147 The burst strength testing protocol was adapted 
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from the ASTM D3786/D3786M: Bursting Strength of Textile Fabrics Method. The 
mechanical evaluation of the burst strength was performed for 1-layer, 2-layer, 3-layer, and 
6-layer multi-laminar patches demonstrated an average impact resistance of at 4.26 ± 0.40 
MPa, 7.53 ± 0.52 MPa, 10.75 ± 1.47 MPa, and 18.49 ± 0.76 MPa for, respectively (Figure 
12).147 Statistical difference (p < 0.05) was observed between all testing groups. 
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Figure 12: Burst resistance testing indicates multi-laminate AF patches can withstand 
quasi-static application of pressure commonly experienced in the IVD. 
Representative graph of the average maximum calculated burst pressure for 1-, 2-, 3-
, and 6-layer patches. (Dotted horizontal line indicates highest measured in vivo 
human IDP reported in literature [2.3 MPa observed while bent over with a round 
back while lifting 20 kg.]) * indicates significant difference (p < 0.05). Picture 
reproduced with permission of R. McGuire.147  
 
 
* 
* 
* 
* 
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DYNAMIC TENSILE FATIGUE TESTING 
One of the two primary spinal motions in the lumbar region is flexion. The bending 
motion associated with flexion is resisted by the posterior annulus and posterior 
longitudinal ligament. The ability of the AF patch to resist varying stress amplitudes during 
tensile fatigue loading was evaluated. Dynamic tensile fatigue testing of 3-layered multi-
laminate AF patches was performed to predict the relative lifespan/endurance of the patch. 
Representative samples were tested to a mechanical run out of 10,000 cycles over a range 
of stress amplitudes observed during flexion to develop an S-N curve. Testing was 
conducted at stress amplitudes ranging between 0.95-2.66 MPa (25-70% UTS of the native 
human AF). AF patches withstood at minimum 1155 ± 75 cycles and achieved an 
endurance limit of 10,000 cycles at stress amplitudes of 2.66 MPa and 0.95 MPa, 
respectively. The S-N curve (Figure 13) illustrates the recorded data for AF patch overlaid 
on values reported for human AF tested under the same conditions. Supplemental data of 
Detailed applied load and cycles to failure of cyclic tensile fatigue experiments are listed 
in (TABLE 6).  
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Figure 13: Tensile fatigue endurance of 3-layer AF patch approximates that of the 
native human AF. S-N Curve illustrating the fatigue strength of our 3-layered multi-
laminate AF patch (triangles), in comparison of native human AF (diamonds).101 A 
negative correlation between the level of applied stress and the number of loading 
cycles to failure was observed. Open diamonds, triangles, and arrows indicate 
specimens with no mechanical failure observed (mechanical run out to 10,000 cycles).  
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Table 6: Detailed applied load and cycles to failure of cyclic tensile fatigue 
experiments with native AF (left) vs. 3-layered multi-laminate AF patch (right) based 
on representative UTS (Ultimate Tensile Strength) percentages. Tests were halted 
following a mechanical run out to 10,000 cycles. 
 
CELLULAR ANALYSIS 
Cellular studies were conducted on 3-layered multi-laminate angle-ply AF patches 
to ensure cell viability on all layers of the patch. Previous laboratory testing showed that 
bovine AFCs were viable on the surfaces of the patches through day 15 studies;147 however, 
following histological analysis cell viability between the upper and lower layers were 
previously unidentifiable. To provide the greatest chance of probability of cell attachment, 
Load (% UTS) Load (MPa) Cycles to failure Load (% UTS) Load (MPa) Cycles to failure
41 1.56 10000 50 1.90 3740
46 1.75 10000 50 1.90 7810
47 1.79 1835 50 1.90 4590
49 1.86 10000 45 1.71 2200
54 2.05 10000 45 1.71 5630
54 2.05 10000 45 1.71 5350
55 2.09 14 25 0.95 10000
56 2.13 1860 26 0.99 10000
59 2.24 371 60 2.28 2350
59 2.24 4245 30 1.14 10000
61 2.32 5 40 1.52 10000
63 2.39 15 60 2.28 1850
63 2.39 960 70 2.66 1230
64 2.43 215 70 2.66 1080
64 2.43 2720
65 2.47 27
68 2.58 700
71 2.70 195
91 3.46 5
Multi-layered AF PatchNative AF
7
Loading Details
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a volume optimization protocol was used to determine the total amount of volume (µl of 
cell culture media containing AF cells) an AF patch was capable of holding to prevent run-
off. It was determined a 7 x 7 x 0.8 mm3 AF patch was capable of holding 45 µl on the top 
and bottom layers, and 75 µl between the layers before run-off occurred.  
Tissue disruption modification (sonication) was used with the hypothesis of 
disrupting the tissue extracellular matrix to provide more nutrient transfer to the inner 
layers. Histological analysis of representative control and sonicated 3-layered multi-
laminate AF patches of days 3 and 6, respectively, illustrated cell attachment and 
infiltration (Figure 14). Histological evaluation illustrates AF cell attachment on all layers 
of the multi-laminate AF patch for all samples and time points investigated.  
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Figure 14: Multi-laminate AF patches support AF cell viability, and infiltration 
demonstrated through stained H&E (purple = cellular nuclei, pink = ECM) samples. 
A-B) Representative histological cross-sectional images depicting the presence of AF 
cells within the tissue of a 3–layer multi-laminate AF patch at days 3 and 6 stained 
with H&E (magnification: 100X). C-D) Representative cross-sectional histological 
images depicting the presence of AF cells within the tissue of a 3–layer multi-laminate 
sonicated AF patch at days 3 and 6 stained with H&E (magnification: 200X and 50X, 
respectively).  
Representative sections of day 6 AF patches for sonicated and controlled tissues 
were magnified to perceive clearly the cells infiltrated into the tissue (Figure 15). The 
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width of the representative tissue layers were measured and recorded at 538 µm and 483 
µm (Table 7). Average measured cell penetration depths for sonicated and control sample 
AF patches, measured using ImageJ software, were 278 µm and 52 µm, respectively. The 
furthest depth of cell infiltration were 503 µm (93.7% overall depth relative to tissue width) 
and 327 µm (67.7% overall depth relative to tissue width). A statistical difference (p < 
0.05) was observed between the average cell infiltrations of sonicated and control patches 
on day 6.  
 
  
Figure 15: Increased magnification of a multi-laminate AF patch section, one of the 
three layers, depicting infiltration of cells into the tissue layers for day 6 sonicated 
and controlled AF patches. (Left) Sonicated tissue treated for 20 minutes at time point 
day 6. (Right) Control tissue at time point day 6. (Left and Right original 
magnification: 200X).  
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Table 7: Measurement and analysis were conducted to illustrate cell infiltration. To 
determine the depth of penetration by the AF cells H&E histological staining and 
ImageJ software were used. Representative sections of a 3-layered multi-laminate AF 
patch were magnified (Figure 9) to perceive clearly the cells for sonicated and control 
tissue samples. Width of the representative tissue layers were measured, and 
average/deepest depth of cell infiltration was analyzed for sonicated and control tissue 
samples, respectively. For average and deepest cell infiltration, the percentage of 
overall depth relative to tissue width is displayed in parenthesis. * indicates significant 
difference (p < 0.05). 
Day 6 (AF Patch) Cell Infiltration Measurement 
      
  Sonicated Control 
Width of Layer 538 µm 483 µm 
      
Average Cell Infiltration* 278 µm 
(51.7%) 
52 µm 
(10.7%) 
      
Deepest Cell Infiltration 503 µm 
(93.5%) 
327 µm 
(67.7%) 
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CHAPTER IV 
DISCUSSION 
Effective biological AF repair is an unmet clinical need for several applications: to 
prevent recurrent IVDHs, to preserve the IVD biological structure and functionality, and/or 
to support NP arthroplasty devices for patients with early stage interventions targeting 
IVDD. An ideal AF repair device must mimic the biological, structural, and functional 
characteristics while promoting tissue regeneration. The native AF is comprised of highly 
organized lamellae of aligned type I collagen fibers. When entirely intact, the AF confines 
the NP to the center of the IVD and provides resistance to IDP generated by the NP. When 
a defect is present, the associated underlying pathology and surgical repair typically 
contribute to long-term pain and long-term effects on adjacent IVDs (adjacent segment 
degeneration).  
Until recently, clinicians believed pain associated with IVDH would resolve on its 
own without surgical intervention (i.e. spontaneous resorption of the herniation). However, 
despite a temporary reduction in pain, a recent study indicated when herniations were left 
untreated, a resurgence of pain occurs.50 For patients presenting with radicular symptoms 
or low back pain that is unresponsive to conservative therapy, and demonstrate through 
magnetic resonance imaging (MRI) or computed tomography (CT) confirmation of an NP 
herniation or extrusion, a discectomy procedure is often warranted.148 Annually, there are 
over 500,000 lumbar discectomies performed in the United States.50 While this procedure 
yields satisfactory clinical outcomes, an open pathway (defect) remains which provides a 
path of least resistance for recurrent IVDHs to manifest. It has been shown, the rate of re-
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herniation is greater in patients with an AF defect larger than 6 mm.10,149 The wide variety 
of approaches and techniques used to perform a discectomy can be debated with respect to 
their advantages and disadvantages. While a less aggressive discectomy approach 
(removing the protruding NP fragment without an extensive intradiscal compression) 
results in improved patient outcomes, it does present a greater risk for re-herniation as 
compared to an aggressive approach (removal of more than the protruding NP tissue [disc 
decompression] in attempts to decrease the likelihood that re-herniation may occur).54 
Therefore, an effective AF closure/repair device in conjunction with a less aggressive 
discectomy may result in improved patient outcomes, decreased pain, and fewer revision 
surgeries via lower re-herniation rates.5,6 Additionally, with the application of an AF 
closure device, it could lead to a reduction of chemical pain mediators escaping through 
the open AF following a conventional discectomy, thus reducing the effects of irritation of 
the nerve root ganglion, epidural fibrosis, or the potential for ingrowth of nerve fibers that 
are mediators of postoperative discogenic pain.150–152 
The discectomy procedure itself is not benign to the disc – it is an ablative, not a 
restorative procedure.148 Suturing is a simple and appealing repair method to be used for 
AF closure due to its frequent use during surgery; however, suturing does not account for 
missing AF tissue and may not be strong enough to resist changes in intradiscal pressure 
(IDP).5,6,16 Therefore, there has been an increase in tissue engineering and regenerative 
therapeutic being investigated over the last decade aiming to structurally and biologically 
repair the AF.  
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A need exists to develop an AF closure/repair device that mimic the architecture 
(multi-laminate lamellae of aligned collagen oriented in an angle-ply fashion), mechanical 
properties (ultimate tensile strength and modulus), cytocompatibility (ability to promote 
cell viability and regeneration), and function (ability to resist tensile loading, intradiscal 
pressures, and fatigue) of the native human AF. The objective herein was to confirm our 
ability to generate multi-laminate patches comprised of decellularized porcine pericardium 
with a repeatable angle-ply architecture, to mechanically evaluate their strength and 
durability, and assess their cytocompatibility. It is hypothesized that the AF patches 
composed of decellularized porcine pericardium would mimic the biological, structural, 
and functional characteristics of the native AF, and therefore, be an ideal surrogate for use 
in its repair.   
PATCH FORMATION 
The development of the biomimetic AF patch that mimics the native human AF 
architecture was vital. The alternation of collagen fibers between the native lamellae is the 
underlying foundation of what provides the AF strength when distributing the tensile 
bending and torsional forces throughout the functional spinal unit.153 The parietal 
pericardium layer from porcine hearts was chosen due to its natural underlying structure. 
The parietal pericardium is fused to and inseparable from the fibrous pericardium (most 
superficial layer of the pericardium). It consists of dense and loose connective tissue 
comprised of collagen type I,143 mimicking the native composition of the AF. The dense 
connective tissue is divided into regular and irregular sections. Dense regular connective 
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tissue contains collagen type I fibers bundled in a linear/parallel orientation. The presence 
of these collagen fibers was utilized during fabrication of the scaffold. 
By manually alternating the fiber preferred direction of the dense regular fiber 
architecture of the decellularized porcine pericardium over a light box, a repeatable method 
to overlay consecutive sheets of pericardium achieving an angle-ply orientation was 
developed. Following the alignment of subsequent layers, the patches were secured 
together using suture. The simplicity of this technique combined with the need for different 
sized patch dimensions for testing protocols, patient IVD height, and varying patient AF 
defect sizes allowed for the construction of patches ranging in size from 4 x 4 mm to 30 x 
30 mm using our assembly method. The mean disc height reported for the lumbar segment 
of the spine were 11.6 ± 1.8 mm for the L3/4 disc, 11.3 ± 2.1 mm for the L4/5, and 10.7 ± 
2.1 mm for the L5/S1 level.154 While not surprisingly, the size of an AF defect exhibits an 
enormous effect on the re-herniation rate. In patients with massive AF defects (> ~6-6.5 
mm), the re-herniation rate was 27% compared to patients with slit defects who 
experienced re-herniation rates of only 1%.10 Thus, based on these results, it would indicate 
that if larger defects are effectively reduced in size, re-herniation rates could fall 
dramatically in this “at-risk” group of patients.148 Taken together, we were able to produce 
patch sizes that are of clinical utility. In addition, the development method employed to 
make these patches can be easily scalable for batch manufacturing procedures compared 
to other formation methods of AF scaffolds which require more complex manufacturing 
techniques.155  
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CONFIRMATION OF ANGLE-PLY ARCHITECTURE 
Verifying the proof of concept creating an angle-ply AF patch architecture was 
demonstrated through histological images of single sheets and three layer stacking. 
Masson’s trichrome staining and polarized light microscopy was used to view the fiber 
preferred direction histologically. Polarized light microscopy was used to refract the light 
based on collagen fiber orientation within the individual layer of pericardium. Since 
collagen fibers are an anisotropic material, it expresses birefringent under polarized light. 
With this optical property, the fiber preferred direction of the porcine pericardium were 
clearly visible to correspond to the fibers seen macroscopically. When stacked in multiple 
layers, the AF patch demonstrated the proof of concept for the alternation of fibers with 
the collagen fibers visible in the individual layers aligned coming towards the viewer, and 
the alternating layers oriented away from the viewer.  
MECHANICAL TESTING OF AF PATCH 
Of the available repair methods for AF regeneration, decellularization of an 
extracellular matrix derived scaffold is an attractive option due to its ability to promote the 
expression of M2 macrophages (immune cells with the ability to promote tissue 
homeostasis through cell proliferation and tissue repair)156 and its ability to preserve the 
tissues microenvironment.157 In addition, these attributes promote cell survival, 
proliferation, morphogenesis, differentiation, and constructive tissue remodeling.158,159 
However, the decellularization process of a biological tissue can have potentially 
significant effects on the biomechanical properties of the resulting scaffold. Thus, it is 
critical to evaluate how closely the mechanical characteristics of the resultant AF patch 
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compare to the values of the native human AF. Although the mechanical advantage of 
closing annular defects to retain NP material seems intuitive, only recently have AF closure 
devices been examined for their ability to withstand in situ IDP or flexibility testing.16 For 
this reason, it was paramount to evaluate the mechanical characteristics of our multi-
laminate angle-ply AF patches with respect to tensile strength, impact resistance, and 
tensile fatigue.  
UTS TESTING 
To characterize the maximum tensional stress our AF patch is capable of resisting, 
representative samples were placed under a static tensile load to develop a stress-strain 
relationship. These values were then compared to reported human AF tissue to approximate 
the maximum tensile loads endured by the AF during flexion/bending. The AF patch 
illustrated mechanical properties of UTS and elastic modulus (EM), which fell within the 
reported values of the native human AF (3.8 ± 1.9 MPa, and 12-24MPa, 
respectively).101,102 The biological function of a collagen-based material lies predominantly 
in its mechanical properties. The viscoelastic biological tissue (combined with strong 
underlying cross-linking fibers)160 expressed both viscous and elastic properties when 
undergoing deformation. This particular behavior results from the anisotropic 
microstructure of the AF tissue composed of oriented collagen fibers embedded in the 
ECM.  
The measured UTS represents the maximum stress that the material could withstand 
before failing, and is correlated with the highest stress value on the stress-strain graph. 
Collagen fibers have the optical property of birefringence that defines the direction they 
 75 
can bear a load in a tissue, and the strength of birefringence has been correlated with the 
UTS.161 In a stress-strain relationship, the EM is calculated from the linear portion of the 
graph up to the yield point of the material. As a material stiffness increases it expresses a 
higher EM. The low EM of the AF patch demonstrates its flexibility and ability to change 
shape while maintaining a relatively high UTS similar to the native AF tissue.  
The UTS and EM of the single layer fiber preferred direction were shown to be 
greater than the single layer cross-fiber direction. This is attributable to the mechanical 
function of the collagen fibers that work to resist tension, and while applying a load 
perpendicular to or at an angle from the primary axis of the fiber preferred direction would 
essentially cause the interstitial matrix to endure the majority of the stress, not the fibers 
themselves. The difference seen between the fiber preferred and cross-fiber directions is 
also consistent with acellular scaffolds and continuous fibers in composite materials 
consisting of predominantly collagen fibrils. These acellular scaffolds and continuous 
fibers demonstrated the mechanical properties of the fiber preferred orientation and 
resulted in higher tensile strength and stiffness (elastic modulus) compared to that of the 
cross-fiber preferred direction.162,163  
Analysis of tissue behavior increases in complexity as the hierarchical tissue 
structures become more complicated. The AF patch (aligned with ± 30° alternations 
between subsequent layers) expressed higher UTS compared to single layer tissue aligned 
in the fiber preferred direction and cross-fiber direction. This is consistent with mechanical 
testing of angle-ply laminates which found that opposing (± 30°) constructs were stronger 
than the fiber preferred aligned constructs.132 While another study showed that during 
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uniaxial tensile loading on various fiber angles, the elastic moduli varied with a nonlinear 
decrease seen in modulus with increasing fiber angles.120  
Even though axial rotation and lateral bending in the lumbar discs are relatively 
limited, the range of motion of the IVD in flexion-extension can be as high as 24 degrees.164 
Because the center of rotation of the disc is typically anterior of the posterior AF, the strain 
range of the posterior AF during these high ranges of motion can vary greatly. Maximal 
physiologic strains observed along the AF superficial tissue are about 4% when the disc is 
in compression or torsion, and ~6% when the disc is in flexion or extension, but never 
exceeding 10%.165 Thus, designing a device that can maintain its integrity while sealing 
defects that also go through this strain range is extremely challenging.148 The amount of 
strain experienced to reach the UTS of our AF patch, relative to the native AF tissue UTS, 
was 5.7 ± 0.43 mm. Thus demonstrating the ability of our AF patch to undergoing the 
native strain range, while maintaining its tensile strength integrity.  
FATIGUE TESTING 
To assess the capability of the AF patch withstanding dynamic loading, the AF 
patch underwent tensile fatigue testing for ranges of 25-70% UTS. Upon characterizing the 
UTS of the AF patch, it was necessary to address the levels of stress amplitude commonly 
experienced by the AF during flexion. The representative testing range, of 25-70%, was 
performed based on the lower range limit determined from the resulting endurance limit of 
the AF patch. While the upper range limit was chosen to be 70% (due to the fact, when 
placed in vivo, the IVD is unlikely subjected to stresses higher than 70% UTS due to the 
prevention of injury by ligaments of the neural arch during extension and lateral bending, 
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and through soft tissues during flexion).166 Comparative analysis of the AF patch and native 
human AF, illustrated by Figure 7, demonstrates the AF patches display of a similar S-N 
curve profile relating the level of applied stress to the number of loading cycles withstood 
prior to failure.  
Adapted from a previously published testing protocol for AF tensile fatigue 
testing,101 10,000 cycles were chosen for the mechanical run out of our AF patch. This was 
not to represent a true fatigue limit, but an estimation of how a biological tissue will last in 
a theoretical environment absent of intrinsic healing. While the AF is constantly subjected 
to cyclic tensile loading, typically the higher maximum tensile stresses only occurs during 
a limited range of motions, such as bending forward at the waist (without bending your 
knees), sitting down in a low chair, or tying your shoes. When damage to the AF does 
occur, the intrinsic healing process begins. The AF is identified to heal in three phases: 1st 
phase is when the outer AF begins to heal (day 0 – few weeks), 2nd phase is when the 
interior AF layers gradually heal (few weeks – one-year), and 3rd phase is when there is an 
increase of collagenous fibers within the NP.112 Based on the tensile fatigue results,  the 
AF patch has the capability to resist failure for between 1.0-2.7 years (conservatively 
assuming achievement of maximal flexion approximately 10-25 times per day), which is 
beyond the reported time required for native AF healing (which would eventually help off-
load the mechanical patch responsibilities).112 Therefore, it is reasonable to assume that 
when placed under tensile loading the AF patch is capable of meeting the mechanical 
demands experienced during flexion for the posterolateral AF.  
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IMPACT TESTING 
Impact mechanical testing was performed to obtain the minimum number of layers 
required to withstand the changes of IDP generated by the NP of an IVD. Currently, IDP 
measurement is the only direct way to determine the loading conditions within the human 
spine.48 The posterior region of the AF is inherently weaker due to its more parallel 
alignment to the horizontal axis of the spine compared to other regions.29 Combined with 
instantaneous changes of IDP within preceding IVDH defects and/or discectomy procedure 
sites provide a weakened region in the AF lamellae that have been linked to the rupture of 
the AF; therefore, it was crucial to characterize the impact resistance for the AF patch.167 
The AF patch must be capable of enduring the maximum impact force generated by the NP 
since the vacant area beneath the patch will represent the entire thickness of the AF in the 
repaired region.  
Previously reported by our group, the quasi-static burst strength of the AF patch 
was calculated to determine the approximate amount of layers required to withstand typical 
IDP values generated by the NP.147 While herniations typically occur from a gradual 
degeneration of the disc (weakening of the posterior AF), the rate of IDP change varies 
based on AF tissue degradation and movement of the patient. Currently, no published 
studies specify the speed at which a herniation occurs in nondegenerated IVDs. Using 
calculations based on the reported IDP ranges seen in the native human AF, (0.1-2.3 
MPa),167–169 combined with the idea that an instant change of force can lead to an increase 
in stress concentrations, the AF patches were tested at varying forces with a constant 
velocity of 2.23 m/sec. This velocity is consistent with compression testing conducted to 
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measure the failure mechanisms of the impact loading on the spine,170,171 and represent 
greater speeds than are commonly tested for physiological responses to impact loading.172–
174 The impact resistance measured of AF patches indicated its ability to withstand 
instantaneous changes of IDP observed within the human IVD. A linear increase in average 
impact resistance was observed with increasing the number of pericardium layers within 
the AF patch. While theoretically, the amount of layers required to withstand instantaneous 
changes in IDP commonly observed was less than three layers (optimized value chosen for 
the AF patch), previous results from the quasi-static burst strength testing illustrated a need 
for the minimum of 3-layers. Additionally, this impact mechanical testing does not account 
for repetitive cyclic increases in IDP which would be seen in vivo. Future studies will be 
conducted to measure the efficacy of the patch to resist cyclic IDP and containment of the 
NP material through dynamic compression fatigue resistance testing, following attachment 
to cadaveric IVDs.   
CYTOCOMPATIBILITY OF CELL SEEDING ON AF PATCH 
Aside from the AF patch having mechanical characteristics that closely 
approximate the human AF, it is also made of a biologic material that may lead to the 
promotion of tissue regeneration. This is something that cannot be said about synthetic AF 
repair techniques/materials. The regenerative potential the biological AF patch possesses 
is an advantage in the way it will aid in self-repair and integration. Following attachment 
of the AF patch to the native IVD, the entire mechanical load is supported by the 
biomaterial scaffold and attachment mechanisms. Thus, the patch must maintain sufficient 
mechanical strength to support physiological loading. With the potential increase of 
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integration between the AF patch and native AF tissue over time, the applied loads on the 
patch will decrease; thus, assisting in the durability of the AF patch and attachment 
mechanism. It is reported that AF regeneration could potentially be enhanced by the 
supplementation of cells to accelerate the healing process of large annular defects.130 While 
this is not essential as a mechanical surrogate, the AF patch should be capable of, at the 
minimum, supporting cell viability of cells within the patch as well as potentially promote 
the migration of neighboring cells into the patch.  
Tissue engineering scaffolds are developed to influence the physical, chemical, and 
biological environment surrounding a cell population.175 The use of cells affects the 
scaffolds ability to regenerate the ECM by maintaining the long-term homeostatic balance 
of matrix turnover.176 Therefore, cytocompatibility studies were conducted to evaluate the 
AF patch ability to allow for cell infiltration of viable AF cells. Bovine AF cells were used 
in the current study to test for cytocompatibility of the AF patch with cells representing an 
end-stage phenotype found in the native AF. While bovine AF cells were suitable for 
studying the effects of cell behavior on the AF patch, there is a need for an alternative cell 
source if it is to be used in a clinical setting. Allogenic AF cell isolation requires the patient 
to be subjected to an invasive surgical procedure, and xenogeneic AF cells are not a viable 
option. Therefore, the use of stem cells integrated within the AF patch during implantation 
needs to be investigated to identify potential improvement for regeneration capabilities of 
the patch. This will be addressed in future studies.  
The previous testing conducted in our lab demonstrated the viability of AF cells on 
the outer layers of the AF patch; however, histologically cells were not observed within 
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the inner layers.147 It was assumed that the cells seeded on the inner layers may have 
undergone premature cell death and detached before histological analysis was conducted 
due to the dense ECM preventing the nutrient transfer. However, the current study 
presumed that a non-optimized cell seeding process could have contributed to the failure 
of cells attaching to the inner layers. Therefore, a cell suspension volume optimization 
protocol was developed to ensure cell seeding accuracy. Additionally, ultrasonication 
studies were conducted with the intent of disrupting the ECM of the AF patch layers in 
order to improve nutrient transfer and cell migration within the inner layers of the AF patch.  
The results indicated the AF patch does allow for the attachment and infiltration of 
AF cells in all three layers for an extended period, and is capable of supporting cell 
viability. This was true for both the control (non-sonicated) samples and sonicated samples. 
While the volume optimization protocol ensured cell attachment on the inner layers of the 
AF patch was feasible without tissue disruption, sonicated samples showed a statistical 
difference in the distance cells were capable of infiltrating into the tissue; however, 
sonication treatment of the AF patches could also potentially weaken mechanical 
properties.  
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CHAPTER V 
CONCLUSIONS & RECOMMENDATIONS FOR FUTURE STUDIES 
Coupled with our previously reported findings that illustrate the simplicity and 
scalability of our patch formation method concurrent with its ability to support AF cell 
attachment, these mechanical testing data suggest our AF patch is an ideal surrogate to 
replace and regenerate the native human AF tissue. Overall results show similar mechanical 
properties to native human AF tissue through the ultimate tensile strength and elastic 
moduli, the ability to resist instantaneous changes of IDP, and strength to withstand tensile 
fatigue mimicking the intact (15-25 layer) native human AF. Thus, our device could 
improve patient outcomes and lower healthcare costs for those with IVDH by allowing for 
the utilization of less aggressive discectomy, minimizing the reoccurrence of IVDH, and 
may allow the use of early-stage interventions including nucleus arthroplasty for those with 
IVDD. Future studies should include burst fatigue strength, animal studies, and further 
cellular characterization studies (stem cell seeding, GAG content, and cross-linking 
between the layers).  
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